Validating Rheumatoid Arthritis Remission Using the Patients' Perspective: Results from a Special Interest Group at OMERACT 2016.
Identifieur interne : 000083 ( Main/Exploration ); précédent : 000082; suivant : 000084Validating Rheumatoid Arthritis Remission Using the Patients' Perspective: Results from a Special Interest Group at OMERACT 2016.
Auteurs : Linda A. Rasch ; Maarten Boers ; Catherine L. Hill ; Marieke Voshaar ; Wijnanda Hoogland ; Maarten De Wit ; Caroline Flurey ; Bev Davis ; Merete Lund Hetland ; Cecilie Heegaard Brahe ; Laure Gossec ; George A. Wells ; Peter Tugwell ; Bindee Kuriya ; Niti Goel ; Jasvinder A. Singh ; Cátia Duarte ; José Da Silva ; Dirkjan Van Schaardenburg ; Susanna Proudman ; Lilian H D. Van TuylSource :
- The Journal of rheumatology [ 0315-162X ] ; 2017.
Abstract
The Outcome Measures in Rheumatology (OMERACT) working group on the patients' perspective on remission in rheumatoid arthritis (RA) has been working on this topic since 2010. At OMERACT 2016, progress and preliminary data on validity of measurement instruments for pain, fatigue, and independence in remission in RA were presented, and future directions were explored.
DOI: 10.3899/jrheum.161111
PubMed: 28765250
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000806
- to stream PubMed, to step Curation: 000803
- to stream PubMed, to step Checkpoint: 000803
- to stream Ncbi, to step Merge: 004C23
- to stream Ncbi, to step Curation: 004C23
- to stream Ncbi, to step Checkpoint: 004C23
- to stream Main, to step Merge: 000078
- to stream Main, to step Curation: 000083
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Validating Rheumatoid Arthritis Remission Using the Patients' Perspective: Results from a Special Interest Group at OMERACT 2016.</title><author><name sortKey="Rasch, Linda A" sort="Rasch, Linda A" uniqKey="Rasch L" first="Linda A" last="Rasch">Linda A. Rasch</name><affiliation><nlm:affiliation>From the Amsterdam Rheumatology and Immunology Center | VU University Medical Center; Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, the Netherlands; Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide, Adelaide, Australia; University of the West of England, Bristol, UK; Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet, Glostrup, Denmark; Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Department of Medicine, University of Ottawa, Ottawa; University of Toronto, Toronto, Ontario, Canada; Quintiles and Duke University School of Medicine, Durham, North Carolina; University of Alabama at Birmingham, Birmingham, Alabama, USA; Faculty of Medicine and Academic Hospital, University of Coimbra, Coimbra, Portugal. The validation study was funded by an unrestricted educational grant from Pfizer. L.A. Rasch, MSc, Amsterdam Rheumatology and Immunology Center | VU University Medical Center; M. Boers, MD, MSc, PhD, Professor, Epidemiology and Biostatistics, VU University Medical Center, and Amsterdam Rheumatology and Immunology Center | Reade; C.L. Hill, MD, Professor, University of Adelaide; M. Voshaar, MSc, Patient Partner; W. Hoogland, MD, Patient Partner; M. de Wit, PhD, Patient Partner; C. Flurey, PhD, University of the West of England; B. Davis, Patient Partner; M.L. Hetland, MD, PhD, Professor, Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet; C.H. Brahe, MD, Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet; L. Gossec, MD, PhD, Professor, Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology; G.A. Wells, MD, Professor, University of Ottawa; P. Tugwell, MD, Professor, Department of Medicine, University of Ottawa; B. Kuriya, MD, University of Toronto; N. Goel, MD, Assistant Professor, Quintiles and Duke University School of Medicine; J.A. Singh, MBBS, MPH, Professor, University of Alabama at Birmingham; C. Duarte, MD, Faculty of Medicine and Academic Hospital, University of Coimbra; J. Da Silva, MD, PhD, Professor, Faculty of Medicine and Academic Hospital, University of Coimbra; D. van Schaardenburg, MD, PhD, Professor, Amsterdam Rheumatology and Immunology Center | Reade; S. Proudman, MBBS, Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide; L.H. van Tuyl, PhD, MBA, Amsterdam Rheumatology and Immunology Center | VU University Medical Center. Address correspondence to L.A. Rasch, VU University Medical Center, Department of Rheumatology, Room ZH3A-54, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands. E-mail: l.rasch@vumc.nl. Accepted for publication June 1, 2017.</nlm:affiliation><wicri:noCountry code="subField">2017</wicri:noCountry></affiliation></author><author><name sortKey="Boers, Maarten" sort="Boers, Maarten" uniqKey="Boers M" first="Maarten" last="Boers">Maarten Boers</name><affiliation><nlm:affiliation>From the Amsterdam Rheumatology and Immunology Center | VU University Medical Center; Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, the Netherlands; Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide, Adelaide, Australia; University of the West of England, Bristol, UK; Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet, Glostrup, Denmark; Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Department of Medicine, University of Ottawa, Ottawa; University of Toronto, Toronto, Ontario, Canada; Quintiles and Duke University School of Medicine, Durham, North Carolina; University of Alabama at Birmingham, Birmingham, Alabama, USA; Faculty of Medicine and Academic Hospital, University of Coimbra, Coimbra, Portugal. The validation study was funded by an unrestricted educational grant from Pfizer. L.A. Rasch, MSc, Amsterdam Rheumatology and Immunology Center | VU University Medical Center; M. Boers, MD, MSc, PhD, Professor, Epidemiology and Biostatistics, VU University Medical Center, and Amsterdam Rheumatology and Immunology Center | Reade; C.L. Hill, MD, Professor, University of Adelaide; M. Voshaar, MSc, Patient Partner; W. Hoogland, MD, Patient Partner; M. de Wit, PhD, Patient Partner; C. Flurey, PhD, University of the West of England; B. Davis, Patient Partner; M.L. Hetland, MD, PhD, Professor, Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet; C.H. Brahe, MD, Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet; L. Gossec, MD, PhD, Professor, Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology; G.A. Wells, MD, Professor, University of Ottawa; P. Tugwell, MD, Professor, Department of Medicine, University of Ottawa; B. Kuriya, MD, University of Toronto; N. Goel, MD, Assistant Professor, Quintiles and Duke University School of Medicine; J.A. Singh, MBBS, MPH, Professor, University of Alabama at Birmingham; C. Duarte, MD, Faculty of Medicine and Academic Hospital, University of Coimbra; J. Da Silva, MD, PhD, Professor, Faculty of Medicine and Academic Hospital, University of Coimbra; D. van Schaardenburg, MD, PhD, Professor, Amsterdam Rheumatology and Immunology Center | Reade; S. Proudman, MBBS, Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide; L.H. van Tuyl, PhD, MBA, Amsterdam Rheumatology and Immunology Center | VU University Medical Center. Address correspondence to L.A. Rasch, VU University Medical Center, Department of Rheumatology, Room ZH3A-54, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands. E-mail: l.rasch@vumc.nl. Accepted for publication June 1, 2017.</nlm:affiliation><wicri:noCountry code="subField">2017</wicri:noCountry></affiliation></author><author><name sortKey="Hill, Catherine L" sort="Hill, Catherine L" uniqKey="Hill C" first="Catherine L" last="Hill">Catherine L. Hill</name><affiliation><nlm:affiliation>From the Amsterdam Rheumatology and Immunology Center | VU University Medical Center; Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, the Netherlands; Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide, Adelaide, Australia; University of the West of England, Bristol, UK; Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet, Glostrup, Denmark; Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Department of Medicine, University of Ottawa, Ottawa; University of Toronto, Toronto, Ontario, Canada; Quintiles and Duke University School of Medicine, Durham, North Carolina; University of Alabama at Birmingham, Birmingham, Alabama, USA; Faculty of Medicine and Academic Hospital, University of Coimbra, Coimbra, Portugal. The validation study was funded by an unrestricted educational grant from Pfizer. L.A. Rasch, MSc, Amsterdam Rheumatology and Immunology Center | VU University Medical Center; M. Boers, MD, MSc, PhD, Professor, Epidemiology and Biostatistics, VU University Medical Center, and Amsterdam Rheumatology and Immunology Center | Reade; C.L. Hill, MD, Professor, University of Adelaide; M. Voshaar, MSc, Patient Partner; W. Hoogland, MD, Patient Partner; M. de Wit, PhD, Patient Partner; C. Flurey, PhD, University of the West of England; B. Davis, Patient Partner; M.L. Hetland, MD, PhD, Professor, Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet; C.H. Brahe, MD, Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet; L. Gossec, MD, PhD, Professor, Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology; G.A. Wells, MD, Professor, University of Ottawa; P. Tugwell, MD, Professor, Department of Medicine, University of Ottawa; B. Kuriya, MD, University of Toronto; N. Goel, MD, Assistant Professor, Quintiles and Duke University School of Medicine; J.A. Singh, MBBS, MPH, Professor, University of Alabama at Birmingham; C. Duarte, MD, Faculty of Medicine and Academic Hospital, University of Coimbra; J. Da Silva, MD, PhD, Professor, Faculty of Medicine and Academic Hospital, University of Coimbra; D. van Schaardenburg, MD, PhD, Professor, Amsterdam Rheumatology and Immunology Center | Reade; S. Proudman, MBBS, Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide; L.H. van Tuyl, PhD, MBA, Amsterdam Rheumatology and Immunology Center | VU University Medical Center. Address correspondence to L.A. Rasch, VU University Medical Center, Department of Rheumatology, Room ZH3A-54, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands. E-mail: l.rasch@vumc.nl. Accepted for publication June 1, 2017.</nlm:affiliation><wicri:noCountry code="subField">2017</wicri:noCountry></affiliation></author><author><name sortKey="Voshaar, Marieke" sort="Voshaar, Marieke" uniqKey="Voshaar M" first="Marieke" last="Voshaar">Marieke Voshaar</name><affiliation><nlm:affiliation>From the Amsterdam Rheumatology and Immunology Center | VU University Medical Center; Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, the Netherlands; Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide, Adelaide, Australia; University of the West of England, Bristol, UK; Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet, Glostrup, Denmark; Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Department of Medicine, University of Ottawa, Ottawa; University of Toronto, Toronto, Ontario, Canada; Quintiles and Duke University School of Medicine, Durham, North Carolina; University of Alabama at Birmingham, Birmingham, Alabama, USA; Faculty of Medicine and Academic Hospital, University of Coimbra, Coimbra, Portugal. The validation study was funded by an unrestricted educational grant from Pfizer. L.A. Rasch, MSc, Amsterdam Rheumatology and Immunology Center | VU University Medical Center; M. Boers, MD, MSc, PhD, Professor, Epidemiology and Biostatistics, VU University Medical Center, and Amsterdam Rheumatology and Immunology Center | Reade; C.L. Hill, MD, Professor, University of Adelaide; M. Voshaar, MSc, Patient Partner; W. Hoogland, MD, Patient Partner; M. de Wit, PhD, Patient Partner; C. Flurey, PhD, University of the West of England; B. Davis, Patient Partner; M.L. Hetland, MD, PhD, Professor, Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet; C.H. Brahe, MD, Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet; L. Gossec, MD, PhD, Professor, Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology; G.A. Wells, MD, Professor, University of Ottawa; P. Tugwell, MD, Professor, Department of Medicine, University of Ottawa; B. Kuriya, MD, University of Toronto; N. Goel, MD, Assistant Professor, Quintiles and Duke University School of Medicine; J.A. Singh, MBBS, MPH, Professor, University of Alabama at Birmingham; C. Duarte, MD, Faculty of Medicine and Academic Hospital, University of Coimbra; J. Da Silva, MD, PhD, Professor, Faculty of Medicine and Academic Hospital, University of Coimbra; D. van Schaardenburg, MD, PhD, Professor, Amsterdam Rheumatology and Immunology Center | Reade; S. Proudman, MBBS, Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide; L.H. van Tuyl, PhD, MBA, Amsterdam Rheumatology and Immunology Center | VU University Medical Center. Address correspondence to L.A. Rasch, VU University Medical Center, Department of Rheumatology, Room ZH3A-54, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands. E-mail: l.rasch@vumc.nl. Accepted for publication June 1, 2017.</nlm:affiliation><wicri:noCountry code="subField">2017</wicri:noCountry></affiliation></author><author><name sortKey="Hoogland, Wijnanda" sort="Hoogland, Wijnanda" uniqKey="Hoogland W" first="Wijnanda" last="Hoogland">Wijnanda Hoogland</name><affiliation><nlm:affiliation>From the Amsterdam Rheumatology and Immunology Center | VU University Medical Center; Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, the Netherlands; Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide, Adelaide, Australia; University of the West of England, Bristol, UK; Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet, Glostrup, Denmark; Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Department of Medicine, University of Ottawa, Ottawa; University of Toronto, Toronto, Ontario, Canada; Quintiles and Duke University School of Medicine, Durham, North Carolina; University of Alabama at Birmingham, Birmingham, Alabama, USA; Faculty of Medicine and Academic Hospital, University of Coimbra, Coimbra, Portugal. The validation study was funded by an unrestricted educational grant from Pfizer. L.A. Rasch, MSc, Amsterdam Rheumatology and Immunology Center | VU University Medical Center; M. Boers, MD, MSc, PhD, Professor, Epidemiology and Biostatistics, VU University Medical Center, and Amsterdam Rheumatology and Immunology Center | Reade; C.L. Hill, MD, Professor, University of Adelaide; M. Voshaar, MSc, Patient Partner; W. Hoogland, MD, Patient Partner; M. de Wit, PhD, Patient Partner; C. Flurey, PhD, University of the West of England; B. Davis, Patient Partner; M.L. Hetland, MD, PhD, Professor, Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet; C.H. Brahe, MD, Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet; L. Gossec, MD, PhD, Professor, Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology; G.A. Wells, MD, Professor, University of Ottawa; P. Tugwell, MD, Professor, Department of Medicine, University of Ottawa; B. Kuriya, MD, University of Toronto; N. Goel, MD, Assistant Professor, Quintiles and Duke University School of Medicine; J.A. Singh, MBBS, MPH, Professor, University of Alabama at Birmingham; C. Duarte, MD, Faculty of Medicine and Academic Hospital, University of Coimbra; J. Da Silva, MD, PhD, Professor, Faculty of Medicine and Academic Hospital, University of Coimbra; D. van Schaardenburg, MD, PhD, Professor, Amsterdam Rheumatology and Immunology Center | Reade; S. Proudman, MBBS, Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide; L.H. van Tuyl, PhD, MBA, Amsterdam Rheumatology and Immunology Center | VU University Medical Center. Address correspondence to L.A. Rasch, VU University Medical Center, Department of Rheumatology, Room ZH3A-54, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands. E-mail: l.rasch@vumc.nl. Accepted for publication June 1, 2017.</nlm:affiliation><wicri:noCountry code="subField">2017</wicri:noCountry></affiliation></author><author><name sortKey="De Wit, Maarten" sort="De Wit, Maarten" uniqKey="De Wit M" first="Maarten" last="De Wit">Maarten De Wit</name><affiliation><nlm:affiliation>From the Amsterdam Rheumatology and Immunology Center | VU University Medical Center; Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, the Netherlands; Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide, Adelaide, Australia; University of the West of England, Bristol, UK; Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet, Glostrup, Denmark; Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Department of Medicine, University of Ottawa, Ottawa; University of Toronto, Toronto, Ontario, Canada; Quintiles and Duke University School of Medicine, Durham, North Carolina; University of Alabama at Birmingham, Birmingham, Alabama, USA; Faculty of Medicine and Academic Hospital, University of Coimbra, Coimbra, Portugal. The validation study was funded by an unrestricted educational grant from Pfizer. L.A. Rasch, MSc, Amsterdam Rheumatology and Immunology Center | VU University Medical Center; M. Boers, MD, MSc, PhD, Professor, Epidemiology and Biostatistics, VU University Medical Center, and Amsterdam Rheumatology and Immunology Center | Reade; C.L. Hill, MD, Professor, University of Adelaide; M. Voshaar, MSc, Patient Partner; W. Hoogland, MD, Patient Partner; M. de Wit, PhD, Patient Partner; C. Flurey, PhD, University of the West of England; B. Davis, Patient Partner; M.L. Hetland, MD, PhD, Professor, Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet; C.H. Brahe, MD, Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet; L. Gossec, MD, PhD, Professor, Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology; G.A. Wells, MD, Professor, University of Ottawa; P. Tugwell, MD, Professor, Department of Medicine, University of Ottawa; B. Kuriya, MD, University of Toronto; N. Goel, MD, Assistant Professor, Quintiles and Duke University School of Medicine; J.A. Singh, MBBS, MPH, Professor, University of Alabama at Birmingham; C. Duarte, MD, Faculty of Medicine and Academic Hospital, University of Coimbra; J. Da Silva, MD, PhD, Professor, Faculty of Medicine and Academic Hospital, University of Coimbra; D. van Schaardenburg, MD, PhD, Professor, Amsterdam Rheumatology and Immunology Center | Reade; S. Proudman, MBBS, Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide; L.H. van Tuyl, PhD, MBA, Amsterdam Rheumatology and Immunology Center | VU University Medical Center. Address correspondence to L.A. Rasch, VU University Medical Center, Department of Rheumatology, Room ZH3A-54, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands. E-mail: l.rasch@vumc.nl. Accepted for publication June 1, 2017.</nlm:affiliation><wicri:noCountry code="subField">2017</wicri:noCountry></affiliation></author><author><name sortKey="Flurey, Caroline" sort="Flurey, Caroline" uniqKey="Flurey C" first="Caroline" last="Flurey">Caroline Flurey</name><affiliation><nlm:affiliation>From the Amsterdam Rheumatology and Immunology Center | VU University Medical Center; Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, the Netherlands; Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide, Adelaide, Australia; University of the West of England, Bristol, UK; Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet, Glostrup, Denmark; Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Department of Medicine, University of Ottawa, Ottawa; University of Toronto, Toronto, Ontario, Canada; Quintiles and Duke University School of Medicine, Durham, North Carolina; University of Alabama at Birmingham, Birmingham, Alabama, USA; Faculty of Medicine and Academic Hospital, University of Coimbra, Coimbra, Portugal. The validation study was funded by an unrestricted educational grant from Pfizer. L.A. Rasch, MSc, Amsterdam Rheumatology and Immunology Center | VU University Medical Center; M. Boers, MD, MSc, PhD, Professor, Epidemiology and Biostatistics, VU University Medical Center, and Amsterdam Rheumatology and Immunology Center | Reade; C.L. Hill, MD, Professor, University of Adelaide; M. Voshaar, MSc, Patient Partner; W. Hoogland, MD, Patient Partner; M. de Wit, PhD, Patient Partner; C. Flurey, PhD, University of the West of England; B. Davis, Patient Partner; M.L. Hetland, MD, PhD, Professor, Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet; C.H. Brahe, MD, Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet; L. Gossec, MD, PhD, Professor, Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology; G.A. Wells, MD, Professor, University of Ottawa; P. Tugwell, MD, Professor, Department of Medicine, University of Ottawa; B. Kuriya, MD, University of Toronto; N. Goel, MD, Assistant Professor, Quintiles and Duke University School of Medicine; J.A. Singh, MBBS, MPH, Professor, University of Alabama at Birmingham; C. Duarte, MD, Faculty of Medicine and Academic Hospital, University of Coimbra; J. Da Silva, MD, PhD, Professor, Faculty of Medicine and Academic Hospital, University of Coimbra; D. van Schaardenburg, MD, PhD, Professor, Amsterdam Rheumatology and Immunology Center | Reade; S. Proudman, MBBS, Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide; L.H. van Tuyl, PhD, MBA, Amsterdam Rheumatology and Immunology Center | VU University Medical Center. Address correspondence to L.A. Rasch, VU University Medical Center, Department of Rheumatology, Room ZH3A-54, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands. E-mail: l.rasch@vumc.nl. Accepted for publication June 1, 2017.</nlm:affiliation><wicri:noCountry code="subField">2017</wicri:noCountry></affiliation></author><author><name sortKey="Davis, Bev" sort="Davis, Bev" uniqKey="Davis B" first="Bev" last="Davis">Bev Davis</name><affiliation><nlm:affiliation>From the Amsterdam Rheumatology and Immunology Center | VU University Medical Center; Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, the Netherlands; Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide, Adelaide, Australia; University of the West of England, Bristol, UK; Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet, Glostrup, Denmark; Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Department of Medicine, University of Ottawa, Ottawa; University of Toronto, Toronto, Ontario, Canada; Quintiles and Duke University School of Medicine, Durham, North Carolina; University of Alabama at Birmingham, Birmingham, Alabama, USA; Faculty of Medicine and Academic Hospital, University of Coimbra, Coimbra, Portugal. The validation study was funded by an unrestricted educational grant from Pfizer. L.A. Rasch, MSc, Amsterdam Rheumatology and Immunology Center | VU University Medical Center; M. Boers, MD, MSc, PhD, Professor, Epidemiology and Biostatistics, VU University Medical Center, and Amsterdam Rheumatology and Immunology Center | Reade; C.L. Hill, MD, Professor, University of Adelaide; M. Voshaar, MSc, Patient Partner; W. Hoogland, MD, Patient Partner; M. de Wit, PhD, Patient Partner; C. Flurey, PhD, University of the West of England; B. Davis, Patient Partner; M.L. Hetland, MD, PhD, Professor, Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet; C.H. Brahe, MD, Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet; L. Gossec, MD, PhD, Professor, Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology; G.A. Wells, MD, Professor, University of Ottawa; P. Tugwell, MD, Professor, Department of Medicine, University of Ottawa; B. Kuriya, MD, University of Toronto; N. Goel, MD, Assistant Professor, Quintiles and Duke University School of Medicine; J.A. Singh, MBBS, MPH, Professor, University of Alabama at Birmingham; C. Duarte, MD, Faculty of Medicine and Academic Hospital, University of Coimbra; J. Da Silva, MD, PhD, Professor, Faculty of Medicine and Academic Hospital, University of Coimbra; D. van Schaardenburg, MD, PhD, Professor, Amsterdam Rheumatology and Immunology Center | Reade; S. Proudman, MBBS, Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide; L.H. van Tuyl, PhD, MBA, Amsterdam Rheumatology and Immunology Center | VU University Medical Center. Address correspondence to L.A. Rasch, VU University Medical Center, Department of Rheumatology, Room ZH3A-54, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands. E-mail: l.rasch@vumc.nl. Accepted for publication June 1, 2017.</nlm:affiliation><wicri:noCountry code="subField">2017</wicri:noCountry></affiliation></author><author><name sortKey="Hetland, Merete Lund" sort="Hetland, Merete Lund" uniqKey="Hetland M" first="Merete Lund" last="Hetland">Merete Lund Hetland</name><affiliation><nlm:affiliation>From the Amsterdam Rheumatology and Immunology Center | VU University Medical Center; Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, the Netherlands; Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide, Adelaide, Australia; University of the West of England, Bristol, UK; Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet, Glostrup, Denmark; Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Department of Medicine, University of Ottawa, Ottawa; University of Toronto, Toronto, Ontario, Canada; Quintiles and Duke University School of Medicine, Durham, North Carolina; University of Alabama at Birmingham, Birmingham, Alabama, USA; Faculty of Medicine and Academic Hospital, University of Coimbra, Coimbra, Portugal. The validation study was funded by an unrestricted educational grant from Pfizer. L.A. Rasch, MSc, Amsterdam Rheumatology and Immunology Center | VU University Medical Center; M. Boers, MD, MSc, PhD, Professor, Epidemiology and Biostatistics, VU University Medical Center, and Amsterdam Rheumatology and Immunology Center | Reade; C.L. Hill, MD, Professor, University of Adelaide; M. Voshaar, MSc, Patient Partner; W. Hoogland, MD, Patient Partner; M. de Wit, PhD, Patient Partner; C. Flurey, PhD, University of the West of England; B. Davis, Patient Partner; M.L. Hetland, MD, PhD, Professor, Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet; C.H. Brahe, MD, Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet; L. Gossec, MD, PhD, Professor, Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology; G.A. Wells, MD, Professor, University of Ottawa; P. Tugwell, MD, Professor, Department of Medicine, University of Ottawa; B. Kuriya, MD, University of Toronto; N. Goel, MD, Assistant Professor, Quintiles and Duke University School of Medicine; J.A. Singh, MBBS, MPH, Professor, University of Alabama at Birmingham; C. Duarte, MD, Faculty of Medicine and Academic Hospital, University of Coimbra; J. Da Silva, MD, PhD, Professor, Faculty of Medicine and Academic Hospital, University of Coimbra; D. van Schaardenburg, MD, PhD, Professor, Amsterdam Rheumatology and Immunology Center | Reade; S. Proudman, MBBS, Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide; L.H. van Tuyl, PhD, MBA, Amsterdam Rheumatology and Immunology Center | VU University Medical Center. Address correspondence to L.A. Rasch, VU University Medical Center, Department of Rheumatology, Room ZH3A-54, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands. E-mail: l.rasch@vumc.nl. Accepted for publication June 1, 2017.</nlm:affiliation><wicri:noCountry code="subField">2017</wicri:noCountry></affiliation></author><author><name sortKey="Brahe, Cecilie Heegaard" sort="Brahe, Cecilie Heegaard" uniqKey="Brahe C" first="Cecilie Heegaard" last="Brahe">Cecilie Heegaard Brahe</name><affiliation><nlm:affiliation>From the Amsterdam Rheumatology and Immunology Center | VU University Medical Center; Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, the Netherlands; Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide, Adelaide, Australia; University of the West of England, Bristol, UK; Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet, Glostrup, Denmark; Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Department of Medicine, University of Ottawa, Ottawa; University of Toronto, Toronto, Ontario, Canada; Quintiles and Duke University School of Medicine, Durham, North Carolina; University of Alabama at Birmingham, Birmingham, Alabama, USA; Faculty of Medicine and Academic Hospital, University of Coimbra, Coimbra, Portugal. The validation study was funded by an unrestricted educational grant from Pfizer. L.A. Rasch, MSc, Amsterdam Rheumatology and Immunology Center | VU University Medical Center; M. Boers, MD, MSc, PhD, Professor, Epidemiology and Biostatistics, VU University Medical Center, and Amsterdam Rheumatology and Immunology Center | Reade; C.L. Hill, MD, Professor, University of Adelaide; M. Voshaar, MSc, Patient Partner; W. Hoogland, MD, Patient Partner; M. de Wit, PhD, Patient Partner; C. Flurey, PhD, University of the West of England; B. Davis, Patient Partner; M.L. Hetland, MD, PhD, Professor, Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet; C.H. Brahe, MD, Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet; L. Gossec, MD, PhD, Professor, Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology; G.A. Wells, MD, Professor, University of Ottawa; P. Tugwell, MD, Professor, Department of Medicine, University of Ottawa; B. Kuriya, MD, University of Toronto; N. Goel, MD, Assistant Professor, Quintiles and Duke University School of Medicine; J.A. Singh, MBBS, MPH, Professor, University of Alabama at Birmingham; C. Duarte, MD, Faculty of Medicine and Academic Hospital, University of Coimbra; J. Da Silva, MD, PhD, Professor, Faculty of Medicine and Academic Hospital, University of Coimbra; D. van Schaardenburg, MD, PhD, Professor, Amsterdam Rheumatology and Immunology Center | Reade; S. Proudman, MBBS, Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide; L.H. van Tuyl, PhD, MBA, Amsterdam Rheumatology and Immunology Center | VU University Medical Center. Address correspondence to L.A. Rasch, VU University Medical Center, Department of Rheumatology, Room ZH3A-54, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands. E-mail: l.rasch@vumc.nl. Accepted for publication June 1, 2017.</nlm:affiliation><wicri:noCountry code="subField">2017</wicri:noCountry></affiliation></author><author><name sortKey="Gossec, Laure" sort="Gossec, Laure" uniqKey="Gossec L" first="Laure" last="Gossec">Laure Gossec</name><affiliation><nlm:affiliation>From the Amsterdam Rheumatology and Immunology Center | VU University Medical Center; Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, the Netherlands; Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide, Adelaide, Australia; University of the West of England, Bristol, UK; Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet, Glostrup, Denmark; Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Department of Medicine, University of Ottawa, Ottawa; University of Toronto, Toronto, Ontario, Canada; Quintiles and Duke University School of Medicine, Durham, North Carolina; University of Alabama at Birmingham, Birmingham, Alabama, USA; Faculty of Medicine and Academic Hospital, University of Coimbra, Coimbra, Portugal. The validation study was funded by an unrestricted educational grant from Pfizer. L.A. Rasch, MSc, Amsterdam Rheumatology and Immunology Center | VU University Medical Center; M. Boers, MD, MSc, PhD, Professor, Epidemiology and Biostatistics, VU University Medical Center, and Amsterdam Rheumatology and Immunology Center | Reade; C.L. Hill, MD, Professor, University of Adelaide; M. Voshaar, MSc, Patient Partner; W. Hoogland, MD, Patient Partner; M. de Wit, PhD, Patient Partner; C. Flurey, PhD, University of the West of England; B. Davis, Patient Partner; M.L. Hetland, MD, PhD, Professor, Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet; C.H. Brahe, MD, Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet; L. Gossec, MD, PhD, Professor, Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology; G.A. Wells, MD, Professor, University of Ottawa; P. Tugwell, MD, Professor, Department of Medicine, University of Ottawa; B. Kuriya, MD, University of Toronto; N. Goel, MD, Assistant Professor, Quintiles and Duke University School of Medicine; J.A. Singh, MBBS, MPH, Professor, University of Alabama at Birmingham; C. Duarte, MD, Faculty of Medicine and Academic Hospital, University of Coimbra; J. Da Silva, MD, PhD, Professor, Faculty of Medicine and Academic Hospital, University of Coimbra; D. van Schaardenburg, MD, PhD, Professor, Amsterdam Rheumatology and Immunology Center | Reade; S. Proudman, MBBS, Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide; L.H. van Tuyl, PhD, MBA, Amsterdam Rheumatology and Immunology Center | VU University Medical Center. Address correspondence to L.A. Rasch, VU University Medical Center, Department of Rheumatology, Room ZH3A-54, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands. E-mail: l.rasch@vumc.nl. Accepted for publication June 1, 2017.</nlm:affiliation><wicri:noCountry code="subField">2017</wicri:noCountry></affiliation></author><author><name sortKey="Wells, George A" sort="Wells, George A" uniqKey="Wells G" first="George A" last="Wells">George A. Wells</name><affiliation><nlm:affiliation>From the Amsterdam Rheumatology and Immunology Center | VU University Medical Center; Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, the Netherlands; Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide, Adelaide, Australia; University of the West of England, Bristol, UK; Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet, Glostrup, Denmark; Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Department of Medicine, University of Ottawa, Ottawa; University of Toronto, Toronto, Ontario, Canada; Quintiles and Duke University School of Medicine, Durham, North Carolina; University of Alabama at Birmingham, Birmingham, Alabama, USA; Faculty of Medicine and Academic Hospital, University of Coimbra, Coimbra, Portugal. The validation study was funded by an unrestricted educational grant from Pfizer. L.A. Rasch, MSc, Amsterdam Rheumatology and Immunology Center | VU University Medical Center; M. Boers, MD, MSc, PhD, Professor, Epidemiology and Biostatistics, VU University Medical Center, and Amsterdam Rheumatology and Immunology Center | Reade; C.L. Hill, MD, Professor, University of Adelaide; M. Voshaar, MSc, Patient Partner; W. Hoogland, MD, Patient Partner; M. de Wit, PhD, Patient Partner; C. Flurey, PhD, University of the West of England; B. Davis, Patient Partner; M.L. Hetland, MD, PhD, Professor, Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet; C.H. Brahe, MD, Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet; L. Gossec, MD, PhD, Professor, Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology; G.A. Wells, MD, Professor, University of Ottawa; P. Tugwell, MD, Professor, Department of Medicine, University of Ottawa; B. Kuriya, MD, University of Toronto; N. Goel, MD, Assistant Professor, Quintiles and Duke University School of Medicine; J.A. Singh, MBBS, MPH, Professor, University of Alabama at Birmingham; C. Duarte, MD, Faculty of Medicine and Academic Hospital, University of Coimbra; J. Da Silva, MD, PhD, Professor, Faculty of Medicine and Academic Hospital, University of Coimbra; D. van Schaardenburg, MD, PhD, Professor, Amsterdam Rheumatology and Immunology Center | Reade; S. Proudman, MBBS, Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide; L.H. van Tuyl, PhD, MBA, Amsterdam Rheumatology and Immunology Center | VU University Medical Center. Address correspondence to L.A. Rasch, VU University Medical Center, Department of Rheumatology, Room ZH3A-54, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands. E-mail: l.rasch@vumc.nl. Accepted for publication June 1, 2017.</nlm:affiliation><wicri:noCountry code="subField">2017</wicri:noCountry></affiliation></author><author><name sortKey="Tugwell, Peter" sort="Tugwell, Peter" uniqKey="Tugwell P" first="Peter" last="Tugwell">Peter Tugwell</name><affiliation><nlm:affiliation>From the Amsterdam Rheumatology and Immunology Center | VU University Medical Center; Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, the Netherlands; Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide, Adelaide, Australia; University of the West of England, Bristol, UK; Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet, Glostrup, Denmark; Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Department of Medicine, University of Ottawa, Ottawa; University of Toronto, Toronto, Ontario, Canada; Quintiles and Duke University School of Medicine, Durham, North Carolina; University of Alabama at Birmingham, Birmingham, Alabama, USA; Faculty of Medicine and Academic Hospital, University of Coimbra, Coimbra, Portugal. The validation study was funded by an unrestricted educational grant from Pfizer. L.A. Rasch, MSc, Amsterdam Rheumatology and Immunology Center | VU University Medical Center; M. Boers, MD, MSc, PhD, Professor, Epidemiology and Biostatistics, VU University Medical Center, and Amsterdam Rheumatology and Immunology Center | Reade; C.L. Hill, MD, Professor, University of Adelaide; M. Voshaar, MSc, Patient Partner; W. Hoogland, MD, Patient Partner; M. de Wit, PhD, Patient Partner; C. Flurey, PhD, University of the West of England; B. Davis, Patient Partner; M.L. Hetland, MD, PhD, Professor, Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet; C.H. Brahe, MD, Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet; L. Gossec, MD, PhD, Professor, Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology; G.A. Wells, MD, Professor, University of Ottawa; P. Tugwell, MD, Professor, Department of Medicine, University of Ottawa; B. Kuriya, MD, University of Toronto; N. Goel, MD, Assistant Professor, Quintiles and Duke University School of Medicine; J.A. Singh, MBBS, MPH, Professor, University of Alabama at Birmingham; C. Duarte, MD, Faculty of Medicine and Academic Hospital, University of Coimbra; J. Da Silva, MD, PhD, Professor, Faculty of Medicine and Academic Hospital, University of Coimbra; D. van Schaardenburg, MD, PhD, Professor, Amsterdam Rheumatology and Immunology Center | Reade; S. Proudman, MBBS, Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide; L.H. van Tuyl, PhD, MBA, Amsterdam Rheumatology and Immunology Center | VU University Medical Center. Address correspondence to L.A. Rasch, VU University Medical Center, Department of Rheumatology, Room ZH3A-54, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands. E-mail: l.rasch@vumc.nl. Accepted for publication June 1, 2017.</nlm:affiliation><wicri:noCountry code="subField">2017</wicri:noCountry></affiliation></author><author><name sortKey="Kuriya, Bindee" sort="Kuriya, Bindee" uniqKey="Kuriya B" first="Bindee" last="Kuriya">Bindee Kuriya</name><affiliation><nlm:affiliation>From the Amsterdam Rheumatology and Immunology Center | VU University Medical Center; Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, the Netherlands; Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide, Adelaide, Australia; University of the West of England, Bristol, UK; Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet, Glostrup, Denmark; Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Department of Medicine, University of Ottawa, Ottawa; University of Toronto, Toronto, Ontario, Canada; Quintiles and Duke University School of Medicine, Durham, North Carolina; University of Alabama at Birmingham, Birmingham, Alabama, USA; Faculty of Medicine and Academic Hospital, University of Coimbra, Coimbra, Portugal. The validation study was funded by an unrestricted educational grant from Pfizer. L.A. Rasch, MSc, Amsterdam Rheumatology and Immunology Center | VU University Medical Center; M. Boers, MD, MSc, PhD, Professor, Epidemiology and Biostatistics, VU University Medical Center, and Amsterdam Rheumatology and Immunology Center | Reade; C.L. Hill, MD, Professor, University of Adelaide; M. Voshaar, MSc, Patient Partner; W. Hoogland, MD, Patient Partner; M. de Wit, PhD, Patient Partner; C. Flurey, PhD, University of the West of England; B. Davis, Patient Partner; M.L. Hetland, MD, PhD, Professor, Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet; C.H. Brahe, MD, Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet; L. Gossec, MD, PhD, Professor, Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology; G.A. Wells, MD, Professor, University of Ottawa; P. Tugwell, MD, Professor, Department of Medicine, University of Ottawa; B. Kuriya, MD, University of Toronto; N. Goel, MD, Assistant Professor, Quintiles and Duke University School of Medicine; J.A. Singh, MBBS, MPH, Professor, University of Alabama at Birmingham; C. Duarte, MD, Faculty of Medicine and Academic Hospital, University of Coimbra; J. Da Silva, MD, PhD, Professor, Faculty of Medicine and Academic Hospital, University of Coimbra; D. van Schaardenburg, MD, PhD, Professor, Amsterdam Rheumatology and Immunology Center | Reade; S. Proudman, MBBS, Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide; L.H. van Tuyl, PhD, MBA, Amsterdam Rheumatology and Immunology Center | VU University Medical Center. Address correspondence to L.A. Rasch, VU University Medical Center, Department of Rheumatology, Room ZH3A-54, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands. E-mail: l.rasch@vumc.nl. Accepted for publication June 1, 2017.</nlm:affiliation><wicri:noCountry code="subField">2017</wicri:noCountry></affiliation></author><author><name sortKey="Goel, Niti" sort="Goel, Niti" uniqKey="Goel N" first="Niti" last="Goel">Niti Goel</name><affiliation><nlm:affiliation>From the Amsterdam Rheumatology and Immunology Center | VU University Medical Center; Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, the Netherlands; Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide, Adelaide, Australia; University of the West of England, Bristol, UK; Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet, Glostrup, Denmark; Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Department of Medicine, University of Ottawa, Ottawa; University of Toronto, Toronto, Ontario, Canada; Quintiles and Duke University School of Medicine, Durham, North Carolina; University of Alabama at Birmingham, Birmingham, Alabama, USA; Faculty of Medicine and Academic Hospital, University of Coimbra, Coimbra, Portugal. The validation study was funded by an unrestricted educational grant from Pfizer. L.A. Rasch, MSc, Amsterdam Rheumatology and Immunology Center | VU University Medical Center; M. Boers, MD, MSc, PhD, Professor, Epidemiology and Biostatistics, VU University Medical Center, and Amsterdam Rheumatology and Immunology Center | Reade; C.L. Hill, MD, Professor, University of Adelaide; M. Voshaar, MSc, Patient Partner; W. Hoogland, MD, Patient Partner; M. de Wit, PhD, Patient Partner; C. Flurey, PhD, University of the West of England; B. Davis, Patient Partner; M.L. Hetland, MD, PhD, Professor, Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet; C.H. Brahe, MD, Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet; L. Gossec, MD, PhD, Professor, Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology; G.A. Wells, MD, Professor, University of Ottawa; P. Tugwell, MD, Professor, Department of Medicine, University of Ottawa; B. Kuriya, MD, University of Toronto; N. Goel, MD, Assistant Professor, Quintiles and Duke University School of Medicine; J.A. Singh, MBBS, MPH, Professor, University of Alabama at Birmingham; C. Duarte, MD, Faculty of Medicine and Academic Hospital, University of Coimbra; J. Da Silva, MD, PhD, Professor, Faculty of Medicine and Academic Hospital, University of Coimbra; D. van Schaardenburg, MD, PhD, Professor, Amsterdam Rheumatology and Immunology Center | Reade; S. Proudman, MBBS, Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide; L.H. van Tuyl, PhD, MBA, Amsterdam Rheumatology and Immunology Center | VU University Medical Center. Address correspondence to L.A. Rasch, VU University Medical Center, Department of Rheumatology, Room ZH3A-54, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands. E-mail: l.rasch@vumc.nl. Accepted for publication June 1, 2017.</nlm:affiliation><wicri:noCountry code="subField">2017</wicri:noCountry></affiliation></author><author><name sortKey="Singh, Jasvinder A" sort="Singh, Jasvinder A" uniqKey="Singh J" first="Jasvinder A" last="Singh">Jasvinder A. Singh</name><affiliation><nlm:affiliation>From the Amsterdam Rheumatology and Immunology Center | VU University Medical Center; Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, the Netherlands; Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide, Adelaide, Australia; University of the West of England, Bristol, UK; Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet, Glostrup, Denmark; Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Department of Medicine, University of Ottawa, Ottawa; University of Toronto, Toronto, Ontario, Canada; Quintiles and Duke University School of Medicine, Durham, North Carolina; University of Alabama at Birmingham, Birmingham, Alabama, USA; Faculty of Medicine and Academic Hospital, University of Coimbra, Coimbra, Portugal. The validation study was funded by an unrestricted educational grant from Pfizer. L.A. Rasch, MSc, Amsterdam Rheumatology and Immunology Center | VU University Medical Center; M. Boers, MD, MSc, PhD, Professor, Epidemiology and Biostatistics, VU University Medical Center, and Amsterdam Rheumatology and Immunology Center | Reade; C.L. Hill, MD, Professor, University of Adelaide; M. Voshaar, MSc, Patient Partner; W. Hoogland, MD, Patient Partner; M. de Wit, PhD, Patient Partner; C. Flurey, PhD, University of the West of England; B. Davis, Patient Partner; M.L. Hetland, MD, PhD, Professor, Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet; C.H. Brahe, MD, Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet; L. Gossec, MD, PhD, Professor, Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology; G.A. Wells, MD, Professor, University of Ottawa; P. Tugwell, MD, Professor, Department of Medicine, University of Ottawa; B. Kuriya, MD, University of Toronto; N. Goel, MD, Assistant Professor, Quintiles and Duke University School of Medicine; J.A. Singh, MBBS, MPH, Professor, University of Alabama at Birmingham; C. Duarte, MD, Faculty of Medicine and Academic Hospital, University of Coimbra; J. Da Silva, MD, PhD, Professor, Faculty of Medicine and Academic Hospital, University of Coimbra; D. van Schaardenburg, MD, PhD, Professor, Amsterdam Rheumatology and Immunology Center | Reade; S. Proudman, MBBS, Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide; L.H. van Tuyl, PhD, MBA, Amsterdam Rheumatology and Immunology Center | VU University Medical Center. Address correspondence to L.A. Rasch, VU University Medical Center, Department of Rheumatology, Room ZH3A-54, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands. E-mail: l.rasch@vumc.nl. Accepted for publication June 1, 2017.</nlm:affiliation><wicri:noCountry code="subField">2017</wicri:noCountry></affiliation></author><author><name sortKey="Duarte, Catia" sort="Duarte, Catia" uniqKey="Duarte C" first="Cátia" last="Duarte">Cátia Duarte</name><affiliation><nlm:affiliation>From the Amsterdam Rheumatology and Immunology Center | VU University Medical Center; Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, the Netherlands; Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide, Adelaide, Australia; University of the West of England, Bristol, UK; Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet, Glostrup, Denmark; Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Department of Medicine, University of Ottawa, Ottawa; University of Toronto, Toronto, Ontario, Canada; Quintiles and Duke University School of Medicine, Durham, North Carolina; University of Alabama at Birmingham, Birmingham, Alabama, USA; Faculty of Medicine and Academic Hospital, University of Coimbra, Coimbra, Portugal. The validation study was funded by an unrestricted educational grant from Pfizer. L.A. Rasch, MSc, Amsterdam Rheumatology and Immunology Center | VU University Medical Center; M. Boers, MD, MSc, PhD, Professor, Epidemiology and Biostatistics, VU University Medical Center, and Amsterdam Rheumatology and Immunology Center | Reade; C.L. Hill, MD, Professor, University of Adelaide; M. Voshaar, MSc, Patient Partner; W. Hoogland, MD, Patient Partner; M. de Wit, PhD, Patient Partner; C. Flurey, PhD, University of the West of England; B. Davis, Patient Partner; M.L. Hetland, MD, PhD, Professor, Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet; C.H. Brahe, MD, Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet; L. Gossec, MD, PhD, Professor, Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology; G.A. Wells, MD, Professor, University of Ottawa; P. Tugwell, MD, Professor, Department of Medicine, University of Ottawa; B. Kuriya, MD, University of Toronto; N. Goel, MD, Assistant Professor, Quintiles and Duke University School of Medicine; J.A. Singh, MBBS, MPH, Professor, University of Alabama at Birmingham; C. Duarte, MD, Faculty of Medicine and Academic Hospital, University of Coimbra; J. Da Silva, MD, PhD, Professor, Faculty of Medicine and Academic Hospital, University of Coimbra; D. van Schaardenburg, MD, PhD, Professor, Amsterdam Rheumatology and Immunology Center | Reade; S. Proudman, MBBS, Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide; L.H. van Tuyl, PhD, MBA, Amsterdam Rheumatology and Immunology Center | VU University Medical Center. Address correspondence to L.A. Rasch, VU University Medical Center, Department of Rheumatology, Room ZH3A-54, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands. E-mail: l.rasch@vumc.nl. Accepted for publication June 1, 2017.</nlm:affiliation><wicri:noCountry code="subField">2017</wicri:noCountry></affiliation></author><author><name sortKey="Da Silva, Jose" sort="Da Silva, Jose" uniqKey="Da Silva J" first="José" last="Da Silva">José Da Silva</name><affiliation><nlm:affiliation>From the Amsterdam Rheumatology and Immunology Center | VU University Medical Center; Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, the Netherlands; Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide, Adelaide, Australia; University of the West of England, Bristol, UK; Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet, Glostrup, Denmark; Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Department of Medicine, University of Ottawa, Ottawa; University of Toronto, Toronto, Ontario, Canada; Quintiles and Duke University School of Medicine, Durham, North Carolina; University of Alabama at Birmingham, Birmingham, Alabama, USA; Faculty of Medicine and Academic Hospital, University of Coimbra, Coimbra, Portugal. The validation study was funded by an unrestricted educational grant from Pfizer. L.A. Rasch, MSc, Amsterdam Rheumatology and Immunology Center | VU University Medical Center; M. Boers, MD, MSc, PhD, Professor, Epidemiology and Biostatistics, VU University Medical Center, and Amsterdam Rheumatology and Immunology Center | Reade; C.L. Hill, MD, Professor, University of Adelaide; M. Voshaar, MSc, Patient Partner; W. Hoogland, MD, Patient Partner; M. de Wit, PhD, Patient Partner; C. Flurey, PhD, University of the West of England; B. Davis, Patient Partner; M.L. Hetland, MD, PhD, Professor, Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet; C.H. Brahe, MD, Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet; L. Gossec, MD, PhD, Professor, Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology; G.A. Wells, MD, Professor, University of Ottawa; P. Tugwell, MD, Professor, Department of Medicine, University of Ottawa; B. Kuriya, MD, University of Toronto; N. Goel, MD, Assistant Professor, Quintiles and Duke University School of Medicine; J.A. Singh, MBBS, MPH, Professor, University of Alabama at Birmingham; C. Duarte, MD, Faculty of Medicine and Academic Hospital, University of Coimbra; J. Da Silva, MD, PhD, Professor, Faculty of Medicine and Academic Hospital, University of Coimbra; D. van Schaardenburg, MD, PhD, Professor, Amsterdam Rheumatology and Immunology Center | Reade; S. Proudman, MBBS, Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide; L.H. van Tuyl, PhD, MBA, Amsterdam Rheumatology and Immunology Center | VU University Medical Center. Address correspondence to L.A. Rasch, VU University Medical Center, Department of Rheumatology, Room ZH3A-54, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands. E-mail: l.rasch@vumc.nl. Accepted for publication June 1, 2017.</nlm:affiliation><wicri:noCountry code="subField">2017</wicri:noCountry></affiliation></author><author><name sortKey="Van Schaardenburg, Dirkjan" sort="Van Schaardenburg, Dirkjan" uniqKey="Van Schaardenburg D" first="Dirkjan" last="Van Schaardenburg">Dirkjan Van Schaardenburg</name><affiliation><nlm:affiliation>From the Amsterdam Rheumatology and Immunology Center | VU University Medical Center; Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, the Netherlands; Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide, Adelaide, Australia; University of the West of England, Bristol, UK; Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet, Glostrup, Denmark; Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Department of Medicine, University of Ottawa, Ottawa; University of Toronto, Toronto, Ontario, Canada; Quintiles and Duke University School of Medicine, Durham, North Carolina; University of Alabama at Birmingham, Birmingham, Alabama, USA; Faculty of Medicine and Academic Hospital, University of Coimbra, Coimbra, Portugal. The validation study was funded by an unrestricted educational grant from Pfizer. L.A. Rasch, MSc, Amsterdam Rheumatology and Immunology Center | VU University Medical Center; M. Boers, MD, MSc, PhD, Professor, Epidemiology and Biostatistics, VU University Medical Center, and Amsterdam Rheumatology and Immunology Center | Reade; C.L. Hill, MD, Professor, University of Adelaide; M. Voshaar, MSc, Patient Partner; W. Hoogland, MD, Patient Partner; M. de Wit, PhD, Patient Partner; C. Flurey, PhD, University of the West of England; B. Davis, Patient Partner; M.L. Hetland, MD, PhD, Professor, Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet; C.H. Brahe, MD, Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet; L. Gossec, MD, PhD, Professor, Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology; G.A. Wells, MD, Professor, University of Ottawa; P. Tugwell, MD, Professor, Department of Medicine, University of Ottawa; B. Kuriya, MD, University of Toronto; N. Goel, MD, Assistant Professor, Quintiles and Duke University School of Medicine; J.A. Singh, MBBS, MPH, Professor, University of Alabama at Birmingham; C. Duarte, MD, Faculty of Medicine and Academic Hospital, University of Coimbra; J. Da Silva, MD, PhD, Professor, Faculty of Medicine and Academic Hospital, University of Coimbra; D. van Schaardenburg, MD, PhD, Professor, Amsterdam Rheumatology and Immunology Center | Reade; S. Proudman, MBBS, Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide; L.H. van Tuyl, PhD, MBA, Amsterdam Rheumatology and Immunology Center | VU University Medical Center. Address correspondence to L.A. Rasch, VU University Medical Center, Department of Rheumatology, Room ZH3A-54, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands. E-mail: l.rasch@vumc.nl. Accepted for publication June 1, 2017.</nlm:affiliation><wicri:noCountry code="subField">2017</wicri:noCountry></affiliation></author><author><name sortKey="Proudman, Susanna" sort="Proudman, Susanna" uniqKey="Proudman S" first="Susanna" last="Proudman">Susanna Proudman</name><affiliation><nlm:affiliation>From the Amsterdam Rheumatology and Immunology Center | VU University Medical Center; Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, the Netherlands; Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide, Adelaide, Australia; University of the West of England, Bristol, UK; Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet, Glostrup, Denmark; Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Department of Medicine, University of Ottawa, Ottawa; University of Toronto, Toronto, Ontario, Canada; Quintiles and Duke University School of Medicine, Durham, North Carolina; University of Alabama at Birmingham, Birmingham, Alabama, USA; Faculty of Medicine and Academic Hospital, University of Coimbra, Coimbra, Portugal. The validation study was funded by an unrestricted educational grant from Pfizer. L.A. Rasch, MSc, Amsterdam Rheumatology and Immunology Center | VU University Medical Center; M. Boers, MD, MSc, PhD, Professor, Epidemiology and Biostatistics, VU University Medical Center, and Amsterdam Rheumatology and Immunology Center | Reade; C.L. Hill, MD, Professor, University of Adelaide; M. Voshaar, MSc, Patient Partner; W. Hoogland, MD, Patient Partner; M. de Wit, PhD, Patient Partner; C. Flurey, PhD, University of the West of England; B. Davis, Patient Partner; M.L. Hetland, MD, PhD, Professor, Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet; C.H. Brahe, MD, Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet; L. Gossec, MD, PhD, Professor, Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology; G.A. Wells, MD, Professor, University of Ottawa; P. Tugwell, MD, Professor, Department of Medicine, University of Ottawa; B. Kuriya, MD, University of Toronto; N. Goel, MD, Assistant Professor, Quintiles and Duke University School of Medicine; J.A. Singh, MBBS, MPH, Professor, University of Alabama at Birmingham; C. Duarte, MD, Faculty of Medicine and Academic Hospital, University of Coimbra; J. Da Silva, MD, PhD, Professor, Faculty of Medicine and Academic Hospital, University of Coimbra; D. van Schaardenburg, MD, PhD, Professor, Amsterdam Rheumatology and Immunology Center | Reade; S. Proudman, MBBS, Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide; L.H. van Tuyl, PhD, MBA, Amsterdam Rheumatology and Immunology Center | VU University Medical Center. Address correspondence to L.A. Rasch, VU University Medical Center, Department of Rheumatology, Room ZH3A-54, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands. E-mail: l.rasch@vumc.nl. Accepted for publication June 1, 2017.</nlm:affiliation><wicri:noCountry code="subField">2017</wicri:noCountry></affiliation></author><author><name sortKey="Van Tuyl, Lilian H D" sort="Van Tuyl, Lilian H D" uniqKey="Van Tuyl L" first="Lilian H D" last="Van Tuyl">Lilian H D. Van Tuyl</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2017">2017</date><idno type="RBID">pubmed:28765250</idno><idno type="pmid">28765250</idno><idno type="doi">10.3899/jrheum.161111</idno><idno type="wicri:Area/PubMed/Corpus">000806</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000806</idno><idno type="wicri:Area/PubMed/Curation">000803</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000803</idno><idno type="wicri:Area/PubMed/Checkpoint">000803</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000803</idno><idno type="wicri:Area/Ncbi/Merge">004C23</idno><idno type="wicri:Area/Ncbi/Curation">004C23</idno><idno type="wicri:Area/Ncbi/Checkpoint">004C23</idno><idno type="wicri:doubleKey">0315-162X:2017:Rasch L:validating:rheumatoid:arthritis</idno><idno type="wicri:Area/Main/Merge">000078</idno><idno type="wicri:Area/Main/Curation">000083</idno><idno type="wicri:Area/Main/Exploration">000083</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Validating Rheumatoid Arthritis Remission Using the Patients' Perspective: Results from a Special Interest Group at OMERACT 2016.</title><author><name sortKey="Rasch, Linda A" sort="Rasch, Linda A" uniqKey="Rasch L" first="Linda A" last="Rasch">Linda A. Rasch</name><affiliation><nlm:affiliation>From the Amsterdam Rheumatology and Immunology Center | VU University Medical Center; Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, the Netherlands; Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide, Adelaide, Australia; University of the West of England, Bristol, UK; Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet, Glostrup, Denmark; Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Department of Medicine, University of Ottawa, Ottawa; University of Toronto, Toronto, Ontario, Canada; Quintiles and Duke University School of Medicine, Durham, North Carolina; University of Alabama at Birmingham, Birmingham, Alabama, USA; Faculty of Medicine and Academic Hospital, University of Coimbra, Coimbra, Portugal. The validation study was funded by an unrestricted educational grant from Pfizer. L.A. Rasch, MSc, Amsterdam Rheumatology and Immunology Center | VU University Medical Center; M. Boers, MD, MSc, PhD, Professor, Epidemiology and Biostatistics, VU University Medical Center, and Amsterdam Rheumatology and Immunology Center | Reade; C.L. Hill, MD, Professor, University of Adelaide; M. Voshaar, MSc, Patient Partner; W. Hoogland, MD, Patient Partner; M. de Wit, PhD, Patient Partner; C. Flurey, PhD, University of the West of England; B. Davis, Patient Partner; M.L. Hetland, MD, PhD, Professor, Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet; C.H. Brahe, MD, Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet; L. Gossec, MD, PhD, Professor, Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology; G.A. Wells, MD, Professor, University of Ottawa; P. Tugwell, MD, Professor, Department of Medicine, University of Ottawa; B. Kuriya, MD, University of Toronto; N. Goel, MD, Assistant Professor, Quintiles and Duke University School of Medicine; J.A. Singh, MBBS, MPH, Professor, University of Alabama at Birmingham; C. Duarte, MD, Faculty of Medicine and Academic Hospital, University of Coimbra; J. Da Silva, MD, PhD, Professor, Faculty of Medicine and Academic Hospital, University of Coimbra; D. van Schaardenburg, MD, PhD, Professor, Amsterdam Rheumatology and Immunology Center | Reade; S. Proudman, MBBS, Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide; L.H. van Tuyl, PhD, MBA, Amsterdam Rheumatology and Immunology Center | VU University Medical Center. Address correspondence to L.A. Rasch, VU University Medical Center, Department of Rheumatology, Room ZH3A-54, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands. E-mail: l.rasch@vumc.nl. Accepted for publication June 1, 2017.</nlm:affiliation><wicri:noCountry code="subField">2017</wicri:noCountry></affiliation></author><author><name sortKey="Boers, Maarten" sort="Boers, Maarten" uniqKey="Boers M" first="Maarten" last="Boers">Maarten Boers</name><affiliation><nlm:affiliation>From the Amsterdam Rheumatology and Immunology Center | VU University Medical Center; Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, the Netherlands; Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide, Adelaide, Australia; University of the West of England, Bristol, UK; Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet, Glostrup, Denmark; Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Department of Medicine, University of Ottawa, Ottawa; University of Toronto, Toronto, Ontario, Canada; Quintiles and Duke University School of Medicine, Durham, North Carolina; University of Alabama at Birmingham, Birmingham, Alabama, USA; Faculty of Medicine and Academic Hospital, University of Coimbra, Coimbra, Portugal. The validation study was funded by an unrestricted educational grant from Pfizer. L.A. Rasch, MSc, Amsterdam Rheumatology and Immunology Center | VU University Medical Center; M. Boers, MD, MSc, PhD, Professor, Epidemiology and Biostatistics, VU University Medical Center, and Amsterdam Rheumatology and Immunology Center | Reade; C.L. Hill, MD, Professor, University of Adelaide; M. Voshaar, MSc, Patient Partner; W. Hoogland, MD, Patient Partner; M. de Wit, PhD, Patient Partner; C. Flurey, PhD, University of the West of England; B. Davis, Patient Partner; M.L. Hetland, MD, PhD, Professor, Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet; C.H. Brahe, MD, Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet; L. Gossec, MD, PhD, Professor, Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology; G.A. Wells, MD, Professor, University of Ottawa; P. Tugwell, MD, Professor, Department of Medicine, University of Ottawa; B. Kuriya, MD, University of Toronto; N. Goel, MD, Assistant Professor, Quintiles and Duke University School of Medicine; J.A. Singh, MBBS, MPH, Professor, University of Alabama at Birmingham; C. Duarte, MD, Faculty of Medicine and Academic Hospital, University of Coimbra; J. Da Silva, MD, PhD, Professor, Faculty of Medicine and Academic Hospital, University of Coimbra; D. van Schaardenburg, MD, PhD, Professor, Amsterdam Rheumatology and Immunology Center | Reade; S. Proudman, MBBS, Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide; L.H. van Tuyl, PhD, MBA, Amsterdam Rheumatology and Immunology Center | VU University Medical Center. Address correspondence to L.A. Rasch, VU University Medical Center, Department of Rheumatology, Room ZH3A-54, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands. E-mail: l.rasch@vumc.nl. Accepted for publication June 1, 2017.</nlm:affiliation><wicri:noCountry code="subField">2017</wicri:noCountry></affiliation></author><author><name sortKey="Hill, Catherine L" sort="Hill, Catherine L" uniqKey="Hill C" first="Catherine L" last="Hill">Catherine L. Hill</name><affiliation><nlm:affiliation>From the Amsterdam Rheumatology and Immunology Center | VU University Medical Center; Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, the Netherlands; Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide, Adelaide, Australia; University of the West of England, Bristol, UK; Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet, Glostrup, Denmark; Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Department of Medicine, University of Ottawa, Ottawa; University of Toronto, Toronto, Ontario, Canada; Quintiles and Duke University School of Medicine, Durham, North Carolina; University of Alabama at Birmingham, Birmingham, Alabama, USA; Faculty of Medicine and Academic Hospital, University of Coimbra, Coimbra, Portugal. The validation study was funded by an unrestricted educational grant from Pfizer. L.A. Rasch, MSc, Amsterdam Rheumatology and Immunology Center | VU University Medical Center; M. Boers, MD, MSc, PhD, Professor, Epidemiology and Biostatistics, VU University Medical Center, and Amsterdam Rheumatology and Immunology Center | Reade; C.L. Hill, MD, Professor, University of Adelaide; M. Voshaar, MSc, Patient Partner; W. Hoogland, MD, Patient Partner; M. de Wit, PhD, Patient Partner; C. Flurey, PhD, University of the West of England; B. Davis, Patient Partner; M.L. Hetland, MD, PhD, Professor, Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet; C.H. Brahe, MD, Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet; L. Gossec, MD, PhD, Professor, Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology; G.A. Wells, MD, Professor, University of Ottawa; P. Tugwell, MD, Professor, Department of Medicine, University of Ottawa; B. Kuriya, MD, University of Toronto; N. Goel, MD, Assistant Professor, Quintiles and Duke University School of Medicine; J.A. Singh, MBBS, MPH, Professor, University of Alabama at Birmingham; C. Duarte, MD, Faculty of Medicine and Academic Hospital, University of Coimbra; J. Da Silva, MD, PhD, Professor, Faculty of Medicine and Academic Hospital, University of Coimbra; D. van Schaardenburg, MD, PhD, Professor, Amsterdam Rheumatology and Immunology Center | Reade; S. Proudman, MBBS, Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide; L.H. van Tuyl, PhD, MBA, Amsterdam Rheumatology and Immunology Center | VU University Medical Center. Address correspondence to L.A. Rasch, VU University Medical Center, Department of Rheumatology, Room ZH3A-54, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands. E-mail: l.rasch@vumc.nl. Accepted for publication June 1, 2017.</nlm:affiliation><wicri:noCountry code="subField">2017</wicri:noCountry></affiliation></author><author><name sortKey="Voshaar, Marieke" sort="Voshaar, Marieke" uniqKey="Voshaar M" first="Marieke" last="Voshaar">Marieke Voshaar</name><affiliation><nlm:affiliation>From the Amsterdam Rheumatology and Immunology Center | VU University Medical Center; Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, the Netherlands; Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide, Adelaide, Australia; University of the West of England, Bristol, UK; Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet, Glostrup, Denmark; Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Department of Medicine, University of Ottawa, Ottawa; University of Toronto, Toronto, Ontario, Canada; Quintiles and Duke University School of Medicine, Durham, North Carolina; University of Alabama at Birmingham, Birmingham, Alabama, USA; Faculty of Medicine and Academic Hospital, University of Coimbra, Coimbra, Portugal. The validation study was funded by an unrestricted educational grant from Pfizer. L.A. Rasch, MSc, Amsterdam Rheumatology and Immunology Center | VU University Medical Center; M. Boers, MD, MSc, PhD, Professor, Epidemiology and Biostatistics, VU University Medical Center, and Amsterdam Rheumatology and Immunology Center | Reade; C.L. Hill, MD, Professor, University of Adelaide; M. Voshaar, MSc, Patient Partner; W. Hoogland, MD, Patient Partner; M. de Wit, PhD, Patient Partner; C. Flurey, PhD, University of the West of England; B. Davis, Patient Partner; M.L. Hetland, MD, PhD, Professor, Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet; C.H. Brahe, MD, Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet; L. Gossec, MD, PhD, Professor, Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology; G.A. Wells, MD, Professor, University of Ottawa; P. Tugwell, MD, Professor, Department of Medicine, University of Ottawa; B. Kuriya, MD, University of Toronto; N. Goel, MD, Assistant Professor, Quintiles and Duke University School of Medicine; J.A. Singh, MBBS, MPH, Professor, University of Alabama at Birmingham; C. Duarte, MD, Faculty of Medicine and Academic Hospital, University of Coimbra; J. Da Silva, MD, PhD, Professor, Faculty of Medicine and Academic Hospital, University of Coimbra; D. van Schaardenburg, MD, PhD, Professor, Amsterdam Rheumatology and Immunology Center | Reade; S. Proudman, MBBS, Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide; L.H. van Tuyl, PhD, MBA, Amsterdam Rheumatology and Immunology Center | VU University Medical Center. Address correspondence to L.A. Rasch, VU University Medical Center, Department of Rheumatology, Room ZH3A-54, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands. E-mail: l.rasch@vumc.nl. Accepted for publication June 1, 2017.</nlm:affiliation><wicri:noCountry code="subField">2017</wicri:noCountry></affiliation></author><author><name sortKey="Hoogland, Wijnanda" sort="Hoogland, Wijnanda" uniqKey="Hoogland W" first="Wijnanda" last="Hoogland">Wijnanda Hoogland</name><affiliation><nlm:affiliation>From the Amsterdam Rheumatology and Immunology Center | VU University Medical Center; Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, the Netherlands; Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide, Adelaide, Australia; University of the West of England, Bristol, UK; Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet, Glostrup, Denmark; Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Department of Medicine, University of Ottawa, Ottawa; University of Toronto, Toronto, Ontario, Canada; Quintiles and Duke University School of Medicine, Durham, North Carolina; University of Alabama at Birmingham, Birmingham, Alabama, USA; Faculty of Medicine and Academic Hospital, University of Coimbra, Coimbra, Portugal. The validation study was funded by an unrestricted educational grant from Pfizer. L.A. Rasch, MSc, Amsterdam Rheumatology and Immunology Center | VU University Medical Center; M. Boers, MD, MSc, PhD, Professor, Epidemiology and Biostatistics, VU University Medical Center, and Amsterdam Rheumatology and Immunology Center | Reade; C.L. Hill, MD, Professor, University of Adelaide; M. Voshaar, MSc, Patient Partner; W. Hoogland, MD, Patient Partner; M. de Wit, PhD, Patient Partner; C. Flurey, PhD, University of the West of England; B. Davis, Patient Partner; M.L. Hetland, MD, PhD, Professor, Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet; C.H. Brahe, MD, Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet; L. Gossec, MD, PhD, Professor, Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology; G.A. Wells, MD, Professor, University of Ottawa; P. Tugwell, MD, Professor, Department of Medicine, University of Ottawa; B. Kuriya, MD, University of Toronto; N. Goel, MD, Assistant Professor, Quintiles and Duke University School of Medicine; J.A. Singh, MBBS, MPH, Professor, University of Alabama at Birmingham; C. Duarte, MD, Faculty of Medicine and Academic Hospital, University of Coimbra; J. Da Silva, MD, PhD, Professor, Faculty of Medicine and Academic Hospital, University of Coimbra; D. van Schaardenburg, MD, PhD, Professor, Amsterdam Rheumatology and Immunology Center | Reade; S. Proudman, MBBS, Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide; L.H. van Tuyl, PhD, MBA, Amsterdam Rheumatology and Immunology Center | VU University Medical Center. Address correspondence to L.A. Rasch, VU University Medical Center, Department of Rheumatology, Room ZH3A-54, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands. E-mail: l.rasch@vumc.nl. Accepted for publication June 1, 2017.</nlm:affiliation><wicri:noCountry code="subField">2017</wicri:noCountry></affiliation></author><author><name sortKey="De Wit, Maarten" sort="De Wit, Maarten" uniqKey="De Wit M" first="Maarten" last="De Wit">Maarten De Wit</name><affiliation><nlm:affiliation>From the Amsterdam Rheumatology and Immunology Center | VU University Medical Center; Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, the Netherlands; Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide, Adelaide, Australia; University of the West of England, Bristol, UK; Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet, Glostrup, Denmark; Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Department of Medicine, University of Ottawa, Ottawa; University of Toronto, Toronto, Ontario, Canada; Quintiles and Duke University School of Medicine, Durham, North Carolina; University of Alabama at Birmingham, Birmingham, Alabama, USA; Faculty of Medicine and Academic Hospital, University of Coimbra, Coimbra, Portugal. The validation study was funded by an unrestricted educational grant from Pfizer. L.A. Rasch, MSc, Amsterdam Rheumatology and Immunology Center | VU University Medical Center; M. Boers, MD, MSc, PhD, Professor, Epidemiology and Biostatistics, VU University Medical Center, and Amsterdam Rheumatology and Immunology Center | Reade; C.L. Hill, MD, Professor, University of Adelaide; M. Voshaar, MSc, Patient Partner; W. Hoogland, MD, Patient Partner; M. de Wit, PhD, Patient Partner; C. Flurey, PhD, University of the West of England; B. Davis, Patient Partner; M.L. Hetland, MD, PhD, Professor, Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet; C.H. Brahe, MD, Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet; L. Gossec, MD, PhD, Professor, Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology; G.A. Wells, MD, Professor, University of Ottawa; P. Tugwell, MD, Professor, Department of Medicine, University of Ottawa; B. Kuriya, MD, University of Toronto; N. Goel, MD, Assistant Professor, Quintiles and Duke University School of Medicine; J.A. Singh, MBBS, MPH, Professor, University of Alabama at Birmingham; C. Duarte, MD, Faculty of Medicine and Academic Hospital, University of Coimbra; J. Da Silva, MD, PhD, Professor, Faculty of Medicine and Academic Hospital, University of Coimbra; D. van Schaardenburg, MD, PhD, Professor, Amsterdam Rheumatology and Immunology Center | Reade; S. Proudman, MBBS, Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide; L.H. van Tuyl, PhD, MBA, Amsterdam Rheumatology and Immunology Center | VU University Medical Center. Address correspondence to L.A. Rasch, VU University Medical Center, Department of Rheumatology, Room ZH3A-54, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands. E-mail: l.rasch@vumc.nl. Accepted for publication June 1, 2017.</nlm:affiliation><wicri:noCountry code="subField">2017</wicri:noCountry></affiliation></author><author><name sortKey="Flurey, Caroline" sort="Flurey, Caroline" uniqKey="Flurey C" first="Caroline" last="Flurey">Caroline Flurey</name><affiliation><nlm:affiliation>From the Amsterdam Rheumatology and Immunology Center | VU University Medical Center; Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, the Netherlands; Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide, Adelaide, Australia; University of the West of England, Bristol, UK; Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet, Glostrup, Denmark; Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Department of Medicine, University of Ottawa, Ottawa; University of Toronto, Toronto, Ontario, Canada; Quintiles and Duke University School of Medicine, Durham, North Carolina; University of Alabama at Birmingham, Birmingham, Alabama, USA; Faculty of Medicine and Academic Hospital, University of Coimbra, Coimbra, Portugal. The validation study was funded by an unrestricted educational grant from Pfizer. L.A. Rasch, MSc, Amsterdam Rheumatology and Immunology Center | VU University Medical Center; M. Boers, MD, MSc, PhD, Professor, Epidemiology and Biostatistics, VU University Medical Center, and Amsterdam Rheumatology and Immunology Center | Reade; C.L. Hill, MD, Professor, University of Adelaide; M. Voshaar, MSc, Patient Partner; W. Hoogland, MD, Patient Partner; M. de Wit, PhD, Patient Partner; C. Flurey, PhD, University of the West of England; B. Davis, Patient Partner; M.L. Hetland, MD, PhD, Professor, Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet; C.H. Brahe, MD, Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet; L. Gossec, MD, PhD, Professor, Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology; G.A. Wells, MD, Professor, University of Ottawa; P. Tugwell, MD, Professor, Department of Medicine, University of Ottawa; B. Kuriya, MD, University of Toronto; N. Goel, MD, Assistant Professor, Quintiles and Duke University School of Medicine; J.A. Singh, MBBS, MPH, Professor, University of Alabama at Birmingham; C. Duarte, MD, Faculty of Medicine and Academic Hospital, University of Coimbra; J. Da Silva, MD, PhD, Professor, Faculty of Medicine and Academic Hospital, University of Coimbra; D. van Schaardenburg, MD, PhD, Professor, Amsterdam Rheumatology and Immunology Center | Reade; S. Proudman, MBBS, Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide; L.H. van Tuyl, PhD, MBA, Amsterdam Rheumatology and Immunology Center | VU University Medical Center. Address correspondence to L.A. Rasch, VU University Medical Center, Department of Rheumatology, Room ZH3A-54, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands. E-mail: l.rasch@vumc.nl. Accepted for publication June 1, 2017.</nlm:affiliation><wicri:noCountry code="subField">2017</wicri:noCountry></affiliation></author><author><name sortKey="Davis, Bev" sort="Davis, Bev" uniqKey="Davis B" first="Bev" last="Davis">Bev Davis</name><affiliation><nlm:affiliation>From the Amsterdam Rheumatology and Immunology Center | VU University Medical Center; Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, the Netherlands; Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide, Adelaide, Australia; University of the West of England, Bristol, UK; Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet, Glostrup, Denmark; Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Department of Medicine, University of Ottawa, Ottawa; University of Toronto, Toronto, Ontario, Canada; Quintiles and Duke University School of Medicine, Durham, North Carolina; University of Alabama at Birmingham, Birmingham, Alabama, USA; Faculty of Medicine and Academic Hospital, University of Coimbra, Coimbra, Portugal. The validation study was funded by an unrestricted educational grant from Pfizer. L.A. Rasch, MSc, Amsterdam Rheumatology and Immunology Center | VU University Medical Center; M. Boers, MD, MSc, PhD, Professor, Epidemiology and Biostatistics, VU University Medical Center, and Amsterdam Rheumatology and Immunology Center | Reade; C.L. Hill, MD, Professor, University of Adelaide; M. Voshaar, MSc, Patient Partner; W. Hoogland, MD, Patient Partner; M. de Wit, PhD, Patient Partner; C. Flurey, PhD, University of the West of England; B. Davis, Patient Partner; M.L. Hetland, MD, PhD, Professor, Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet; C.H. Brahe, MD, Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet; L. Gossec, MD, PhD, Professor, Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology; G.A. Wells, MD, Professor, University of Ottawa; P. Tugwell, MD, Professor, Department of Medicine, University of Ottawa; B. Kuriya, MD, University of Toronto; N. Goel, MD, Assistant Professor, Quintiles and Duke University School of Medicine; J.A. Singh, MBBS, MPH, Professor, University of Alabama at Birmingham; C. Duarte, MD, Faculty of Medicine and Academic Hospital, University of Coimbra; J. Da Silva, MD, PhD, Professor, Faculty of Medicine and Academic Hospital, University of Coimbra; D. van Schaardenburg, MD, PhD, Professor, Amsterdam Rheumatology and Immunology Center | Reade; S. Proudman, MBBS, Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide; L.H. van Tuyl, PhD, MBA, Amsterdam Rheumatology and Immunology Center | VU University Medical Center. Address correspondence to L.A. Rasch, VU University Medical Center, Department of Rheumatology, Room ZH3A-54, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands. E-mail: l.rasch@vumc.nl. Accepted for publication June 1, 2017.</nlm:affiliation><wicri:noCountry code="subField">2017</wicri:noCountry></affiliation></author><author><name sortKey="Hetland, Merete Lund" sort="Hetland, Merete Lund" uniqKey="Hetland M" first="Merete Lund" last="Hetland">Merete Lund Hetland</name><affiliation><nlm:affiliation>From the Amsterdam Rheumatology and Immunology Center | VU University Medical Center; Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, the Netherlands; Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide, Adelaide, Australia; University of the West of England, Bristol, UK; Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet, Glostrup, Denmark; Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Department of Medicine, University of Ottawa, Ottawa; University of Toronto, Toronto, Ontario, Canada; Quintiles and Duke University School of Medicine, Durham, North Carolina; University of Alabama at Birmingham, Birmingham, Alabama, USA; Faculty of Medicine and Academic Hospital, University of Coimbra, Coimbra, Portugal. The validation study was funded by an unrestricted educational grant from Pfizer. L.A. Rasch, MSc, Amsterdam Rheumatology and Immunology Center | VU University Medical Center; M. Boers, MD, MSc, PhD, Professor, Epidemiology and Biostatistics, VU University Medical Center, and Amsterdam Rheumatology and Immunology Center | Reade; C.L. Hill, MD, Professor, University of Adelaide; M. Voshaar, MSc, Patient Partner; W. Hoogland, MD, Patient Partner; M. de Wit, PhD, Patient Partner; C. Flurey, PhD, University of the West of England; B. Davis, Patient Partner; M.L. Hetland, MD, PhD, Professor, Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet; C.H. Brahe, MD, Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet; L. Gossec, MD, PhD, Professor, Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology; G.A. Wells, MD, Professor, University of Ottawa; P. Tugwell, MD, Professor, Department of Medicine, University of Ottawa; B. Kuriya, MD, University of Toronto; N. Goel, MD, Assistant Professor, Quintiles and Duke University School of Medicine; J.A. Singh, MBBS, MPH, Professor, University of Alabama at Birmingham; C. Duarte, MD, Faculty of Medicine and Academic Hospital, University of Coimbra; J. Da Silva, MD, PhD, Professor, Faculty of Medicine and Academic Hospital, University of Coimbra; D. van Schaardenburg, MD, PhD, Professor, Amsterdam Rheumatology and Immunology Center | Reade; S. Proudman, MBBS, Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide; L.H. van Tuyl, PhD, MBA, Amsterdam Rheumatology and Immunology Center | VU University Medical Center. Address correspondence to L.A. Rasch, VU University Medical Center, Department of Rheumatology, Room ZH3A-54, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands. E-mail: l.rasch@vumc.nl. Accepted for publication June 1, 2017.</nlm:affiliation><wicri:noCountry code="subField">2017</wicri:noCountry></affiliation></author><author><name sortKey="Brahe, Cecilie Heegaard" sort="Brahe, Cecilie Heegaard" uniqKey="Brahe C" first="Cecilie Heegaard" last="Brahe">Cecilie Heegaard Brahe</name><affiliation><nlm:affiliation>From the Amsterdam Rheumatology and Immunology Center | VU University Medical Center; Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, the Netherlands; Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide, Adelaide, Australia; University of the West of England, Bristol, UK; Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet, Glostrup, Denmark; Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Department of Medicine, University of Ottawa, Ottawa; University of Toronto, Toronto, Ontario, Canada; Quintiles and Duke University School of Medicine, Durham, North Carolina; University of Alabama at Birmingham, Birmingham, Alabama, USA; Faculty of Medicine and Academic Hospital, University of Coimbra, Coimbra, Portugal. The validation study was funded by an unrestricted educational grant from Pfizer. L.A. Rasch, MSc, Amsterdam Rheumatology and Immunology Center | VU University Medical Center; M. Boers, MD, MSc, PhD, Professor, Epidemiology and Biostatistics, VU University Medical Center, and Amsterdam Rheumatology and Immunology Center | Reade; C.L. Hill, MD, Professor, University of Adelaide; M. Voshaar, MSc, Patient Partner; W. Hoogland, MD, Patient Partner; M. de Wit, PhD, Patient Partner; C. Flurey, PhD, University of the West of England; B. Davis, Patient Partner; M.L. Hetland, MD, PhD, Professor, Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet; C.H. Brahe, MD, Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet; L. Gossec, MD, PhD, Professor, Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology; G.A. Wells, MD, Professor, University of Ottawa; P. Tugwell, MD, Professor, Department of Medicine, University of Ottawa; B. Kuriya, MD, University of Toronto; N. Goel, MD, Assistant Professor, Quintiles and Duke University School of Medicine; J.A. Singh, MBBS, MPH, Professor, University of Alabama at Birmingham; C. Duarte, MD, Faculty of Medicine and Academic Hospital, University of Coimbra; J. Da Silva, MD, PhD, Professor, Faculty of Medicine and Academic Hospital, University of Coimbra; D. van Schaardenburg, MD, PhD, Professor, Amsterdam Rheumatology and Immunology Center | Reade; S. Proudman, MBBS, Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide; L.H. van Tuyl, PhD, MBA, Amsterdam Rheumatology and Immunology Center | VU University Medical Center. Address correspondence to L.A. Rasch, VU University Medical Center, Department of Rheumatology, Room ZH3A-54, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands. E-mail: l.rasch@vumc.nl. Accepted for publication June 1, 2017.</nlm:affiliation><wicri:noCountry code="subField">2017</wicri:noCountry></affiliation></author><author><name sortKey="Gossec, Laure" sort="Gossec, Laure" uniqKey="Gossec L" first="Laure" last="Gossec">Laure Gossec</name><affiliation><nlm:affiliation>From the Amsterdam Rheumatology and Immunology Center | VU University Medical Center; Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, the Netherlands; Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide, Adelaide, Australia; University of the West of England, Bristol, UK; Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet, Glostrup, Denmark; Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Department of Medicine, University of Ottawa, Ottawa; University of Toronto, Toronto, Ontario, Canada; Quintiles and Duke University School of Medicine, Durham, North Carolina; University of Alabama at Birmingham, Birmingham, Alabama, USA; Faculty of Medicine and Academic Hospital, University of Coimbra, Coimbra, Portugal. The validation study was funded by an unrestricted educational grant from Pfizer. L.A. Rasch, MSc, Amsterdam Rheumatology and Immunology Center | VU University Medical Center; M. Boers, MD, MSc, PhD, Professor, Epidemiology and Biostatistics, VU University Medical Center, and Amsterdam Rheumatology and Immunology Center | Reade; C.L. Hill, MD, Professor, University of Adelaide; M. Voshaar, MSc, Patient Partner; W. Hoogland, MD, Patient Partner; M. de Wit, PhD, Patient Partner; C. Flurey, PhD, University of the West of England; B. Davis, Patient Partner; M.L. Hetland, MD, PhD, Professor, Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet; C.H. Brahe, MD, Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet; L. Gossec, MD, PhD, Professor, Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology; G.A. Wells, MD, Professor, University of Ottawa; P. Tugwell, MD, Professor, Department of Medicine, University of Ottawa; B. Kuriya, MD, University of Toronto; N. Goel, MD, Assistant Professor, Quintiles and Duke University School of Medicine; J.A. Singh, MBBS, MPH, Professor, University of Alabama at Birmingham; C. Duarte, MD, Faculty of Medicine and Academic Hospital, University of Coimbra; J. Da Silva, MD, PhD, Professor, Faculty of Medicine and Academic Hospital, University of Coimbra; D. van Schaardenburg, MD, PhD, Professor, Amsterdam Rheumatology and Immunology Center | Reade; S. Proudman, MBBS, Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide; L.H. van Tuyl, PhD, MBA, Amsterdam Rheumatology and Immunology Center | VU University Medical Center. Address correspondence to L.A. Rasch, VU University Medical Center, Department of Rheumatology, Room ZH3A-54, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands. E-mail: l.rasch@vumc.nl. Accepted for publication June 1, 2017.</nlm:affiliation><wicri:noCountry code="subField">2017</wicri:noCountry></affiliation></author><author><name sortKey="Wells, George A" sort="Wells, George A" uniqKey="Wells G" first="George A" last="Wells">George A. Wells</name><affiliation><nlm:affiliation>From the Amsterdam Rheumatology and Immunology Center | VU University Medical Center; Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, the Netherlands; Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide, Adelaide, Australia; University of the West of England, Bristol, UK; Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet, Glostrup, Denmark; Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Department of Medicine, University of Ottawa, Ottawa; University of Toronto, Toronto, Ontario, Canada; Quintiles and Duke University School of Medicine, Durham, North Carolina; University of Alabama at Birmingham, Birmingham, Alabama, USA; Faculty of Medicine and Academic Hospital, University of Coimbra, Coimbra, Portugal. The validation study was funded by an unrestricted educational grant from Pfizer. L.A. Rasch, MSc, Amsterdam Rheumatology and Immunology Center | VU University Medical Center; M. Boers, MD, MSc, PhD, Professor, Epidemiology and Biostatistics, VU University Medical Center, and Amsterdam Rheumatology and Immunology Center | Reade; C.L. Hill, MD, Professor, University of Adelaide; M. Voshaar, MSc, Patient Partner; W. Hoogland, MD, Patient Partner; M. de Wit, PhD, Patient Partner; C. Flurey, PhD, University of the West of England; B. Davis, Patient Partner; M.L. Hetland, MD, PhD, Professor, Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet; C.H. Brahe, MD, Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet; L. Gossec, MD, PhD, Professor, Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology; G.A. Wells, MD, Professor, University of Ottawa; P. Tugwell, MD, Professor, Department of Medicine, University of Ottawa; B. Kuriya, MD, University of Toronto; N. Goel, MD, Assistant Professor, Quintiles and Duke University School of Medicine; J.A. Singh, MBBS, MPH, Professor, University of Alabama at Birmingham; C. Duarte, MD, Faculty of Medicine and Academic Hospital, University of Coimbra; J. Da Silva, MD, PhD, Professor, Faculty of Medicine and Academic Hospital, University of Coimbra; D. van Schaardenburg, MD, PhD, Professor, Amsterdam Rheumatology and Immunology Center | Reade; S. Proudman, MBBS, Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide; L.H. van Tuyl, PhD, MBA, Amsterdam Rheumatology and Immunology Center | VU University Medical Center. Address correspondence to L.A. Rasch, VU University Medical Center, Department of Rheumatology, Room ZH3A-54, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands. E-mail: l.rasch@vumc.nl. Accepted for publication June 1, 2017.</nlm:affiliation><wicri:noCountry code="subField">2017</wicri:noCountry></affiliation></author><author><name sortKey="Tugwell, Peter" sort="Tugwell, Peter" uniqKey="Tugwell P" first="Peter" last="Tugwell">Peter Tugwell</name><affiliation><nlm:affiliation>From the Amsterdam Rheumatology and Immunology Center | VU University Medical Center; Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, the Netherlands; Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide, Adelaide, Australia; University of the West of England, Bristol, UK; Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet, Glostrup, Denmark; Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Department of Medicine, University of Ottawa, Ottawa; University of Toronto, Toronto, Ontario, Canada; Quintiles and Duke University School of Medicine, Durham, North Carolina; University of Alabama at Birmingham, Birmingham, Alabama, USA; Faculty of Medicine and Academic Hospital, University of Coimbra, Coimbra, Portugal. The validation study was funded by an unrestricted educational grant from Pfizer. L.A. Rasch, MSc, Amsterdam Rheumatology and Immunology Center | VU University Medical Center; M. Boers, MD, MSc, PhD, Professor, Epidemiology and Biostatistics, VU University Medical Center, and Amsterdam Rheumatology and Immunology Center | Reade; C.L. Hill, MD, Professor, University of Adelaide; M. Voshaar, MSc, Patient Partner; W. Hoogland, MD, Patient Partner; M. de Wit, PhD, Patient Partner; C. Flurey, PhD, University of the West of England; B. Davis, Patient Partner; M.L. Hetland, MD, PhD, Professor, Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet; C.H. Brahe, MD, Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet; L. Gossec, MD, PhD, Professor, Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology; G.A. Wells, MD, Professor, University of Ottawa; P. Tugwell, MD, Professor, Department of Medicine, University of Ottawa; B. Kuriya, MD, University of Toronto; N. Goel, MD, Assistant Professor, Quintiles and Duke University School of Medicine; J.A. Singh, MBBS, MPH, Professor, University of Alabama at Birmingham; C. Duarte, MD, Faculty of Medicine and Academic Hospital, University of Coimbra; J. Da Silva, MD, PhD, Professor, Faculty of Medicine and Academic Hospital, University of Coimbra; D. van Schaardenburg, MD, PhD, Professor, Amsterdam Rheumatology and Immunology Center | Reade; S. Proudman, MBBS, Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide; L.H. van Tuyl, PhD, MBA, Amsterdam Rheumatology and Immunology Center | VU University Medical Center. Address correspondence to L.A. Rasch, VU University Medical Center, Department of Rheumatology, Room ZH3A-54, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands. E-mail: l.rasch@vumc.nl. Accepted for publication June 1, 2017.</nlm:affiliation><wicri:noCountry code="subField">2017</wicri:noCountry></affiliation></author><author><name sortKey="Kuriya, Bindee" sort="Kuriya, Bindee" uniqKey="Kuriya B" first="Bindee" last="Kuriya">Bindee Kuriya</name><affiliation><nlm:affiliation>From the Amsterdam Rheumatology and Immunology Center | VU University Medical Center; Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, the Netherlands; Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide, Adelaide, Australia; University of the West of England, Bristol, UK; Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet, Glostrup, Denmark; Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Department of Medicine, University of Ottawa, Ottawa; University of Toronto, Toronto, Ontario, Canada; Quintiles and Duke University School of Medicine, Durham, North Carolina; University of Alabama at Birmingham, Birmingham, Alabama, USA; Faculty of Medicine and Academic Hospital, University of Coimbra, Coimbra, Portugal. The validation study was funded by an unrestricted educational grant from Pfizer. L.A. Rasch, MSc, Amsterdam Rheumatology and Immunology Center | VU University Medical Center; M. Boers, MD, MSc, PhD, Professor, Epidemiology and Biostatistics, VU University Medical Center, and Amsterdam Rheumatology and Immunology Center | Reade; C.L. Hill, MD, Professor, University of Adelaide; M. Voshaar, MSc, Patient Partner; W. Hoogland, MD, Patient Partner; M. de Wit, PhD, Patient Partner; C. Flurey, PhD, University of the West of England; B. Davis, Patient Partner; M.L. Hetland, MD, PhD, Professor, Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet; C.H. Brahe, MD, Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet; L. Gossec, MD, PhD, Professor, Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology; G.A. Wells, MD, Professor, University of Ottawa; P. Tugwell, MD, Professor, Department of Medicine, University of Ottawa; B. Kuriya, MD, University of Toronto; N. Goel, MD, Assistant Professor, Quintiles and Duke University School of Medicine; J.A. Singh, MBBS, MPH, Professor, University of Alabama at Birmingham; C. Duarte, MD, Faculty of Medicine and Academic Hospital, University of Coimbra; J. Da Silva, MD, PhD, Professor, Faculty of Medicine and Academic Hospital, University of Coimbra; D. van Schaardenburg, MD, PhD, Professor, Amsterdam Rheumatology and Immunology Center | Reade; S. Proudman, MBBS, Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide; L.H. van Tuyl, PhD, MBA, Amsterdam Rheumatology and Immunology Center | VU University Medical Center. Address correspondence to L.A. Rasch, VU University Medical Center, Department of Rheumatology, Room ZH3A-54, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands. E-mail: l.rasch@vumc.nl. Accepted for publication June 1, 2017.</nlm:affiliation><wicri:noCountry code="subField">2017</wicri:noCountry></affiliation></author><author><name sortKey="Goel, Niti" sort="Goel, Niti" uniqKey="Goel N" first="Niti" last="Goel">Niti Goel</name><affiliation><nlm:affiliation>From the Amsterdam Rheumatology and Immunology Center | VU University Medical Center; Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, the Netherlands; Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide, Adelaide, Australia; University of the West of England, Bristol, UK; Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet, Glostrup, Denmark; Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Department of Medicine, University of Ottawa, Ottawa; University of Toronto, Toronto, Ontario, Canada; Quintiles and Duke University School of Medicine, Durham, North Carolina; University of Alabama at Birmingham, Birmingham, Alabama, USA; Faculty of Medicine and Academic Hospital, University of Coimbra, Coimbra, Portugal. The validation study was funded by an unrestricted educational grant from Pfizer. L.A. Rasch, MSc, Amsterdam Rheumatology and Immunology Center | VU University Medical Center; M. Boers, MD, MSc, PhD, Professor, Epidemiology and Biostatistics, VU University Medical Center, and Amsterdam Rheumatology and Immunology Center | Reade; C.L. Hill, MD, Professor, University of Adelaide; M. Voshaar, MSc, Patient Partner; W. Hoogland, MD, Patient Partner; M. de Wit, PhD, Patient Partner; C. Flurey, PhD, University of the West of England; B. Davis, Patient Partner; M.L. Hetland, MD, PhD, Professor, Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet; C.H. Brahe, MD, Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet; L. Gossec, MD, PhD, Professor, Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology; G.A. Wells, MD, Professor, University of Ottawa; P. Tugwell, MD, Professor, Department of Medicine, University of Ottawa; B. Kuriya, MD, University of Toronto; N. Goel, MD, Assistant Professor, Quintiles and Duke University School of Medicine; J.A. Singh, MBBS, MPH, Professor, University of Alabama at Birmingham; C. Duarte, MD, Faculty of Medicine and Academic Hospital, University of Coimbra; J. Da Silva, MD, PhD, Professor, Faculty of Medicine and Academic Hospital, University of Coimbra; D. van Schaardenburg, MD, PhD, Professor, Amsterdam Rheumatology and Immunology Center | Reade; S. Proudman, MBBS, Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide; L.H. van Tuyl, PhD, MBA, Amsterdam Rheumatology and Immunology Center | VU University Medical Center. Address correspondence to L.A. Rasch, VU University Medical Center, Department of Rheumatology, Room ZH3A-54, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands. E-mail: l.rasch@vumc.nl. Accepted for publication June 1, 2017.</nlm:affiliation><wicri:noCountry code="subField">2017</wicri:noCountry></affiliation></author><author><name sortKey="Singh, Jasvinder A" sort="Singh, Jasvinder A" uniqKey="Singh J" first="Jasvinder A" last="Singh">Jasvinder A. Singh</name><affiliation><nlm:affiliation>From the Amsterdam Rheumatology and Immunology Center | VU University Medical Center; Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, the Netherlands; Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide, Adelaide, Australia; University of the West of England, Bristol, UK; Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet, Glostrup, Denmark; Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Department of Medicine, University of Ottawa, Ottawa; University of Toronto, Toronto, Ontario, Canada; Quintiles and Duke University School of Medicine, Durham, North Carolina; University of Alabama at Birmingham, Birmingham, Alabama, USA; Faculty of Medicine and Academic Hospital, University of Coimbra, Coimbra, Portugal. The validation study was funded by an unrestricted educational grant from Pfizer. L.A. Rasch, MSc, Amsterdam Rheumatology and Immunology Center | VU University Medical Center; M. Boers, MD, MSc, PhD, Professor, Epidemiology and Biostatistics, VU University Medical Center, and Amsterdam Rheumatology and Immunology Center | Reade; C.L. Hill, MD, Professor, University of Adelaide; M. Voshaar, MSc, Patient Partner; W. Hoogland, MD, Patient Partner; M. de Wit, PhD, Patient Partner; C. Flurey, PhD, University of the West of England; B. Davis, Patient Partner; M.L. Hetland, MD, PhD, Professor, Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet; C.H. Brahe, MD, Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet; L. Gossec, MD, PhD, Professor, Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology; G.A. Wells, MD, Professor, University of Ottawa; P. Tugwell, MD, Professor, Department of Medicine, University of Ottawa; B. Kuriya, MD, University of Toronto; N. Goel, MD, Assistant Professor, Quintiles and Duke University School of Medicine; J.A. Singh, MBBS, MPH, Professor, University of Alabama at Birmingham; C. Duarte, MD, Faculty of Medicine and Academic Hospital, University of Coimbra; J. Da Silva, MD, PhD, Professor, Faculty of Medicine and Academic Hospital, University of Coimbra; D. van Schaardenburg, MD, PhD, Professor, Amsterdam Rheumatology and Immunology Center | Reade; S. Proudman, MBBS, Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide; L.H. van Tuyl, PhD, MBA, Amsterdam Rheumatology and Immunology Center | VU University Medical Center. Address correspondence to L.A. Rasch, VU University Medical Center, Department of Rheumatology, Room ZH3A-54, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands. E-mail: l.rasch@vumc.nl. Accepted for publication June 1, 2017.</nlm:affiliation><wicri:noCountry code="subField">2017</wicri:noCountry></affiliation></author><author><name sortKey="Duarte, Catia" sort="Duarte, Catia" uniqKey="Duarte C" first="Cátia" last="Duarte">Cátia Duarte</name><affiliation><nlm:affiliation>From the Amsterdam Rheumatology and Immunology Center | VU University Medical Center; Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, the Netherlands; Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide, Adelaide, Australia; University of the West of England, Bristol, UK; Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet, Glostrup, Denmark; Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Department of Medicine, University of Ottawa, Ottawa; University of Toronto, Toronto, Ontario, Canada; Quintiles and Duke University School of Medicine, Durham, North Carolina; University of Alabama at Birmingham, Birmingham, Alabama, USA; Faculty of Medicine and Academic Hospital, University of Coimbra, Coimbra, Portugal. The validation study was funded by an unrestricted educational grant from Pfizer. L.A. Rasch, MSc, Amsterdam Rheumatology and Immunology Center | VU University Medical Center; M. Boers, MD, MSc, PhD, Professor, Epidemiology and Biostatistics, VU University Medical Center, and Amsterdam Rheumatology and Immunology Center | Reade; C.L. Hill, MD, Professor, University of Adelaide; M. Voshaar, MSc, Patient Partner; W. Hoogland, MD, Patient Partner; M. de Wit, PhD, Patient Partner; C. Flurey, PhD, University of the West of England; B. Davis, Patient Partner; M.L. Hetland, MD, PhD, Professor, Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet; C.H. Brahe, MD, Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet; L. Gossec, MD, PhD, Professor, Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology; G.A. Wells, MD, Professor, University of Ottawa; P. Tugwell, MD, Professor, Department of Medicine, University of Ottawa; B. Kuriya, MD, University of Toronto; N. Goel, MD, Assistant Professor, Quintiles and Duke University School of Medicine; J.A. Singh, MBBS, MPH, Professor, University of Alabama at Birmingham; C. Duarte, MD, Faculty of Medicine and Academic Hospital, University of Coimbra; J. Da Silva, MD, PhD, Professor, Faculty of Medicine and Academic Hospital, University of Coimbra; D. van Schaardenburg, MD, PhD, Professor, Amsterdam Rheumatology and Immunology Center | Reade; S. Proudman, MBBS, Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide; L.H. van Tuyl, PhD, MBA, Amsterdam Rheumatology and Immunology Center | VU University Medical Center. Address correspondence to L.A. Rasch, VU University Medical Center, Department of Rheumatology, Room ZH3A-54, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands. E-mail: l.rasch@vumc.nl. Accepted for publication June 1, 2017.</nlm:affiliation><wicri:noCountry code="subField">2017</wicri:noCountry></affiliation></author><author><name sortKey="Da Silva, Jose" sort="Da Silva, Jose" uniqKey="Da Silva J" first="José" last="Da Silva">José Da Silva</name><affiliation><nlm:affiliation>From the Amsterdam Rheumatology and Immunology Center | VU University Medical Center; Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, the Netherlands; Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide, Adelaide, Australia; University of the West of England, Bristol, UK; Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet, Glostrup, Denmark; Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Department of Medicine, University of Ottawa, Ottawa; University of Toronto, Toronto, Ontario, Canada; Quintiles and Duke University School of Medicine, Durham, North Carolina; University of Alabama at Birmingham, Birmingham, Alabama, USA; Faculty of Medicine and Academic Hospital, University of Coimbra, Coimbra, Portugal. The validation study was funded by an unrestricted educational grant from Pfizer. L.A. Rasch, MSc, Amsterdam Rheumatology and Immunology Center | VU University Medical Center; M. Boers, MD, MSc, PhD, Professor, Epidemiology and Biostatistics, VU University Medical Center, and Amsterdam Rheumatology and Immunology Center | Reade; C.L. Hill, MD, Professor, University of Adelaide; M. Voshaar, MSc, Patient Partner; W. Hoogland, MD, Patient Partner; M. de Wit, PhD, Patient Partner; C. Flurey, PhD, University of the West of England; B. Davis, Patient Partner; M.L. Hetland, MD, PhD, Professor, Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet; C.H. Brahe, MD, Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet; L. Gossec, MD, PhD, Professor, Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology; G.A. Wells, MD, Professor, University of Ottawa; P. Tugwell, MD, Professor, Department of Medicine, University of Ottawa; B. Kuriya, MD, University of Toronto; N. Goel, MD, Assistant Professor, Quintiles and Duke University School of Medicine; J.A. Singh, MBBS, MPH, Professor, University of Alabama at Birmingham; C. Duarte, MD, Faculty of Medicine and Academic Hospital, University of Coimbra; J. Da Silva, MD, PhD, Professor, Faculty of Medicine and Academic Hospital, University of Coimbra; D. van Schaardenburg, MD, PhD, Professor, Amsterdam Rheumatology and Immunology Center | Reade; S. Proudman, MBBS, Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide; L.H. van Tuyl, PhD, MBA, Amsterdam Rheumatology and Immunology Center | VU University Medical Center. Address correspondence to L.A. Rasch, VU University Medical Center, Department of Rheumatology, Room ZH3A-54, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands. E-mail: l.rasch@vumc.nl. Accepted for publication June 1, 2017.</nlm:affiliation><wicri:noCountry code="subField">2017</wicri:noCountry></affiliation></author><author><name sortKey="Van Schaardenburg, Dirkjan" sort="Van Schaardenburg, Dirkjan" uniqKey="Van Schaardenburg D" first="Dirkjan" last="Van Schaardenburg">Dirkjan Van Schaardenburg</name><affiliation><nlm:affiliation>From the Amsterdam Rheumatology and Immunology Center | VU University Medical Center; Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, the Netherlands; Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide, Adelaide, Australia; University of the West of England, Bristol, UK; Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet, Glostrup, Denmark; Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Department of Medicine, University of Ottawa, Ottawa; University of Toronto, Toronto, Ontario, Canada; Quintiles and Duke University School of Medicine, Durham, North Carolina; University of Alabama at Birmingham, Birmingham, Alabama, USA; Faculty of Medicine and Academic Hospital, University of Coimbra, Coimbra, Portugal. The validation study was funded by an unrestricted educational grant from Pfizer. L.A. Rasch, MSc, Amsterdam Rheumatology and Immunology Center | VU University Medical Center; M. Boers, MD, MSc, PhD, Professor, Epidemiology and Biostatistics, VU University Medical Center, and Amsterdam Rheumatology and Immunology Center | Reade; C.L. Hill, MD, Professor, University of Adelaide; M. Voshaar, MSc, Patient Partner; W. Hoogland, MD, Patient Partner; M. de Wit, PhD, Patient Partner; C. Flurey, PhD, University of the West of England; B. Davis, Patient Partner; M.L. Hetland, MD, PhD, Professor, Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet; C.H. Brahe, MD, Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet; L. Gossec, MD, PhD, Professor, Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology; G.A. Wells, MD, Professor, University of Ottawa; P. Tugwell, MD, Professor, Department of Medicine, University of Ottawa; B. Kuriya, MD, University of Toronto; N. Goel, MD, Assistant Professor, Quintiles and Duke University School of Medicine; J.A. Singh, MBBS, MPH, Professor, University of Alabama at Birmingham; C. Duarte, MD, Faculty of Medicine and Academic Hospital, University of Coimbra; J. Da Silva, MD, PhD, Professor, Faculty of Medicine and Academic Hospital, University of Coimbra; D. van Schaardenburg, MD, PhD, Professor, Amsterdam Rheumatology and Immunology Center | Reade; S. Proudman, MBBS, Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide; L.H. van Tuyl, PhD, MBA, Amsterdam Rheumatology and Immunology Center | VU University Medical Center. Address correspondence to L.A. Rasch, VU University Medical Center, Department of Rheumatology, Room ZH3A-54, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands. E-mail: l.rasch@vumc.nl. Accepted for publication June 1, 2017.</nlm:affiliation><wicri:noCountry code="subField">2017</wicri:noCountry></affiliation></author><author><name sortKey="Proudman, Susanna" sort="Proudman, Susanna" uniqKey="Proudman S" first="Susanna" last="Proudman">Susanna Proudman</name><affiliation><nlm:affiliation>From the Amsterdam Rheumatology and Immunology Center | VU University Medical Center; Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, the Netherlands; Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide, Adelaide, Australia; University of the West of England, Bristol, UK; Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet, Glostrup, Denmark; Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology, Paris, France; Department of Medicine, University of Ottawa, Ottawa; University of Toronto, Toronto, Ontario, Canada; Quintiles and Duke University School of Medicine, Durham, North Carolina; University of Alabama at Birmingham, Birmingham, Alabama, USA; Faculty of Medicine and Academic Hospital, University of Coimbra, Coimbra, Portugal. The validation study was funded by an unrestricted educational grant from Pfizer. L.A. Rasch, MSc, Amsterdam Rheumatology and Immunology Center | VU University Medical Center; M. Boers, MD, MSc, PhD, Professor, Epidemiology and Biostatistics, VU University Medical Center, and Amsterdam Rheumatology and Immunology Center | Reade; C.L. Hill, MD, Professor, University of Adelaide; M. Voshaar, MSc, Patient Partner; W. Hoogland, MD, Patient Partner; M. de Wit, PhD, Patient Partner; C. Flurey, PhD, University of the West of England; B. Davis, Patient Partner; M.L. Hetland, MD, PhD, Professor, Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet; C.H. Brahe, MD, Copenhagen Center for Arthritis Research and DANBIO, Center for Rheumatology and Spine Diseases, Righospitalet; L. Gossec, MD, PhD, Professor, Sorbonne Universités, UPMC Univ Paris 06; AP-HP, Pitié Salpêtrière Hospital, Department of Rheumatology; G.A. Wells, MD, Professor, University of Ottawa; P. Tugwell, MD, Professor, Department of Medicine, University of Ottawa; B. Kuriya, MD, University of Toronto; N. Goel, MD, Assistant Professor, Quintiles and Duke University School of Medicine; J.A. Singh, MBBS, MPH, Professor, University of Alabama at Birmingham; C. Duarte, MD, Faculty of Medicine and Academic Hospital, University of Coimbra; J. Da Silva, MD, PhD, Professor, Faculty of Medicine and Academic Hospital, University of Coimbra; D. van Schaardenburg, MD, PhD, Professor, Amsterdam Rheumatology and Immunology Center | Reade; S. Proudman, MBBS, Royal Adelaide Hospital and Discipline of Medicine, University of Adelaide; L.H. van Tuyl, PhD, MBA, Amsterdam Rheumatology and Immunology Center | VU University Medical Center. Address correspondence to L.A. Rasch, VU University Medical Center, Department of Rheumatology, Room ZH3A-54, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands. E-mail: l.rasch@vumc.nl. Accepted for publication June 1, 2017.</nlm:affiliation><wicri:noCountry code="subField">2017</wicri:noCountry></affiliation></author><author><name sortKey="Van Tuyl, Lilian H D" sort="Van Tuyl, Lilian H D" uniqKey="Van Tuyl L" first="Lilian H D" last="Van Tuyl">Lilian H D. Van Tuyl</name></author></analytic><series><title level="j">The Journal of rheumatology</title><idno type="ISSN">0315-162X</idno><imprint><date when="2017" type="published">2017</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The Outcome Measures in Rheumatology (OMERACT) working group on the patients' perspective on remission in rheumatoid arthritis (RA) has been working on this topic since 2010. At OMERACT 2016, progress and preliminary data on validity of measurement instruments for pain, fatigue, and independence in remission in RA were presented, and future directions were explored.</div></front></TEI><affiliations><list></list><tree><noCountry><name sortKey="Boers, Maarten" sort="Boers, Maarten" uniqKey="Boers M" first="Maarten" last="Boers">Maarten Boers</name><name sortKey="Brahe, Cecilie Heegaard" sort="Brahe, Cecilie Heegaard" uniqKey="Brahe C" first="Cecilie Heegaard" last="Brahe">Cecilie Heegaard Brahe</name><name sortKey="Da Silva, Jose" sort="Da Silva, Jose" uniqKey="Da Silva J" first="José" last="Da Silva">José Da Silva</name><name sortKey="Davis, Bev" sort="Davis, Bev" uniqKey="Davis B" first="Bev" last="Davis">Bev Davis</name><name sortKey="De Wit, Maarten" sort="De Wit, Maarten" uniqKey="De Wit M" first="Maarten" last="De Wit">Maarten De Wit</name><name sortKey="Duarte, Catia" sort="Duarte, Catia" uniqKey="Duarte C" first="Cátia" last="Duarte">Cátia Duarte</name><name sortKey="Flurey, Caroline" sort="Flurey, Caroline" uniqKey="Flurey C" first="Caroline" last="Flurey">Caroline Flurey</name><name sortKey="Goel, Niti" sort="Goel, Niti" uniqKey="Goel N" first="Niti" last="Goel">Niti Goel</name><name sortKey="Gossec, Laure" sort="Gossec, Laure" uniqKey="Gossec L" first="Laure" last="Gossec">Laure Gossec</name><name sortKey="Hetland, Merete Lund" sort="Hetland, Merete Lund" uniqKey="Hetland M" first="Merete Lund" last="Hetland">Merete Lund Hetland</name><name sortKey="Hill, Catherine L" sort="Hill, Catherine L" uniqKey="Hill C" first="Catherine L" last="Hill">Catherine L. Hill</name><name sortKey="Hoogland, Wijnanda" sort="Hoogland, Wijnanda" uniqKey="Hoogland W" first="Wijnanda" last="Hoogland">Wijnanda Hoogland</name><name sortKey="Kuriya, Bindee" sort="Kuriya, Bindee" uniqKey="Kuriya B" first="Bindee" last="Kuriya">Bindee Kuriya</name><name sortKey="Proudman, Susanna" sort="Proudman, Susanna" uniqKey="Proudman S" first="Susanna" last="Proudman">Susanna Proudman</name><name sortKey="Rasch, Linda A" sort="Rasch, Linda A" uniqKey="Rasch L" first="Linda A" last="Rasch">Linda A. Rasch</name><name sortKey="Singh, Jasvinder A" sort="Singh, Jasvinder A" uniqKey="Singh J" first="Jasvinder A" last="Singh">Jasvinder A. Singh</name><name sortKey="Tugwell, Peter" sort="Tugwell, Peter" uniqKey="Tugwell P" first="Peter" last="Tugwell">Peter Tugwell</name><name sortKey="Van Schaardenburg, Dirkjan" sort="Van Schaardenburg, Dirkjan" uniqKey="Van Schaardenburg D" first="Dirkjan" last="Van Schaardenburg">Dirkjan Van Schaardenburg</name><name sortKey="Van Tuyl, Lilian H D" sort="Van Tuyl, Lilian H D" uniqKey="Van Tuyl L" first="Lilian H D" last="Van Tuyl">Lilian H D. Van Tuyl</name><name sortKey="Voshaar, Marieke" sort="Voshaar, Marieke" uniqKey="Voshaar M" first="Marieke" last="Voshaar">Marieke Voshaar</name><name sortKey="Wells, George A" sort="Wells, George A" uniqKey="Wells G" first="George A" last="Wells">George A. Wells</name></noCountry></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000083 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000083 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:28765250
|texte= Validating Rheumatoid Arthritis Remission Using the Patients' Perspective: Results from a Special Interest Group at OMERACT 2016.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:28765250" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |